<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Hepatology International via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Hepatology International' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Hepatology+International&t=Hepatology+International&s=Search&f=source]]></link>
        <lastBuildDate>Sat, 20 Mar 2010 14:27:49 +0100</lastBuildDate>
        <item>
            <title>Special Chapter: A Scan of Hepatology in Asia Pacific Region</title>
            <link>http://www.medworm.com/index.php?rid=3360897&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5721193537481578%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-010-9174-6

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533
	
		Journal Volume Volume 4
	
		Journal Issue Volume 4, Supplement 1 / March, 2010 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360897</comments>
            <pubDate>Thu, 11 Mar 2010 18:01:44 +0100</pubDate>
            <guid isPermaLink="false">3360897</guid>        </item>
        <item>
            <title>Transplant Course: The Art of Liver Transplantation</title>
            <link>http://www.medworm.com/index.php?rid=3360898&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu47k6569782j1400%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-010-9175-5

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533
	
		Journal Volume Volume 4
	
		Journal Issue Volume 4, Supplement 1 / March, 2010 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360898</comments>
            <pubDate>Thu, 11 Mar 2010 18:01:43 +0100</pubDate>
            <guid isPermaLink="false">3360898</guid>        </item>
        <item>
            <title>The 20th Conference of the Asian Pacific Association for the Study of the Liver Poster Presentation</title>
            <link>http://www.medworm.com/index.php?rid=3360899&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3p5173131v833142%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-010-9169-3

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533
	
		Journal Volume Volume 4
	
		Journal Issue Volume 4, Number 1 / March, 2010 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360899</comments>
            <pubDate>Thu, 11 Mar 2010 07:40:57 +0100</pubDate>
            <guid isPermaLink="false">3360899</guid>        </item>
        <item>
            <title>The 20th Conference of the Asian Pacific Association for the Study of the Liver</title>
            <link>http://www.medworm.com/index.php?rid=3360900&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa8v6251631713675%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-010-9172-8

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533
	
		Journal Volume Volume 4
	
		Journal Issue Volume 4, Number 1 / March, 2010 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360900</comments>
            <pubDate>Thu, 11 Mar 2010 07:40:33 +0100</pubDate>
            <guid isPermaLink="false">3360900</guid>        </item>
        <item>
            <title>The 20th Conference of the Asian Pacific Association for the Study of the Liver Oral Presentations</title>
            <link>http://www.medworm.com/index.php?rid=3360901&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Frx2m87141273x821%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-010-9167-5

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533
	
		Journal Volume Volume 4
	
		Journal Issue Volume 4, Number 1 / March, 2010 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360901</comments>
            <pubDate>Thu, 11 Mar 2010 07:40:28 +0100</pubDate>
            <guid isPermaLink="false">3360901</guid>        </item>
        <item>
            <title>Acknowledgements</title>
            <link>http://www.medworm.com/index.php?rid=3360902&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F962ku286l257655j%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-010-9168-4

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533
	
		Journal Volume Volume 4
	
		Journal Issue Volume 4, Number 1 / March, 2010 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3360902</comments>
            <pubDate>Thu, 11 Mar 2010 07:40:22 +0100</pubDate>
            <guid isPermaLink="false">3360902</guid>        </item>
        <item>
            <title>Postgraduate Course: Integrating Basic Science into Clinical Practice</title>
            <link>http://www.medworm.com/index.php?rid=3308764&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr03tw82821858153%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-010-9173-7

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3308764</comments>
            <pubDate>Wed, 24 Feb 2010 06:55:39 +0100</pubDate>
            <guid isPermaLink="false">3308764</guid>        </item>
        <item>
            <title>N-Acetylcysteine in non-acetaminophen-induced acute liver failure</title>
            <link>http://www.medworm.com/index.php?rid=3304284&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv1200214268188t5%2F</link>
            <description>Content Type Journal ArticleCategory Letter to the EditorDOI 10.1007/s12072-010-9171-9Authors
		Levent Filik, Ankara Research Hospital Gastroenterology Division Altindag 06600 Ankara Turkey
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3304284</comments>
            <pubDate>Tue, 23 Feb 2010 08:03:56 +0100</pubDate>
            <guid isPermaLink="false">3304284</guid>        </item>
        <item>
            <title>Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions</title>
            <link>http://www.medworm.com/index.php?rid=3296180&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq36k81lh8275317q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent guidelines of the American Association for the Study of Liver Diseases, the European Association for the Study of the
 Liver, and the Asian Pacific Association for the Study of the Liver 2008 update of the “Asian-Pacific consensus statement
 on the management of chronic hepatitis B” offer comprehensive recommendations for the general management of chronic hepatitis
 B (CHB). These recommendations highlight preferred approaches to the prevention, diagnosis, and treatment of CHB. Nonetheless,
 the results of recent studies have led to an improved understanding of the disease and a belief that current recommendations
 on specific therapeutic considerations, including CHB treatment initiation and cessation criteria, particularly in patient
 populations with speci...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3296180</comments>
            <pubDate>Sat, 20 Feb 2010 06:57:30 +0100</pubDate>
            <guid isPermaLink="false">3296180</guid>        </item>
        <item>
            <title>Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=3256610&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpv87u84174l10138%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Long-term entecavir treatment of lamivudine-refractory CHB resulted in virologic suppression, ALT normalization, and improvements
 in liver histology. Resistance was consistent with that observed in worldwide studies.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9162-xAuthors
		Yoshiyasu Karino, Sapporo Kosei General Hospital Department of Gastroenterology North 3, East 8, Chuo-ku Sapporo JapanJoji Toyota, Sapporo Kosei General Hospital Department of Gastroenterology North 3, East 8, Chuo-ku Sapporo JapanHiromitsu Kumada, Toranomon Hospital Department of Hepatology Tokyo JapanYoshiaki Katano, Nagoya University Department of Gastroenterology, Graduate School of Medicine Aichi JapanNamiki Izumi, Musashino Red Cross Hospital Departm...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3256610</comments>
            <pubDate>Sat, 06 Feb 2010 08:23:35 +0100</pubDate>
            <guid isPermaLink="false">3256610</guid>        </item>
        <item>
            <title>Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then</title>
            <link>http://www.medworm.com/index.php?rid=3241423&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp44t448712141421%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp; Following hepatitis E epidemics, there is a gradual loss of antibodies in the community over the decades and poor exposure
 to HEV infection in the cohort of population born during the interepidemic period. The next epidemic occurs when antibody
 levels fall to critically low levels and there is associated gross fecal contamination of water resources. During epidemic,
 persons of all age groups are exposed to infection, with predominant anicteric disease in children.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9159-5Authors
		Mehnaaz Sultan Khuroo, Sher-i-Kashmir Institute of Medical Sciences Department of Pathology Soura 190 001 Kashmir IndiaMohammad Sultan Khuroo, Digestive Disease Centre, Dr. Khuroo’s Medical Clinic Srinag...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3241423</comments>
            <pubDate>Tue, 02 Feb 2010 17:55:53 +0100</pubDate>
            <guid isPermaLink="false">3241423</guid>        </item>
        <item>
            <title>Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition?</title>
            <link>http://www.medworm.com/index.php?rid=3229156&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkp74364h7135786u%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The prevalence of DVT in patients with liver cirrhosis was 4.7%, and Deep vein thrombosis is not a rare condition in cirrhotic
 patients with coagulopathy and warrants further studies on the mechanisms and prevention.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9166-6Authors
		Cosmas Rinaldi A. Lesmana, University of Indonesia Department of Internal Medicine Jl. Diponegoro No. 71 Jakarta 10430 IndonesiaSri Inggriani, Radiology Unit, Medistra Hospital Jakarta IndonesiaLidwina Cahyadinata, Digestive Disease Centre, Medistra Hospital Jakarta IndonesiaLaurentius A. Lesmana, Digestive Disease Centre, Medistra Hospital Jakarta Indonesia
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatolog...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3229156</comments>
            <pubDate>Sat, 30 Jan 2010 18:16:12 +0100</pubDate>
            <guid isPermaLink="false">3229156</guid>        </item>
        <item>
            <title>Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer</title>
            <link>http://www.medworm.com/index.php?rid=3224089&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4382368112pr7276%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Although recent progress in adjuvant therapy should be the key to a good prognosis, we believe that surgical resection may
 bring some hope of long-term survival for judiciously selected patients with hepatic metastases from gastric cancer.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9161-yAuthors
		Hironori Tsujimoto, National Defense Medical College Department of Surgery 3-2 Namiki Tokorozawa 359-8513 JapanTakashi Ichikura, National Defense Medical College Department of Surgery 3-2 Namiki Tokorozawa 359-8513 JapanSatoshi Ono, National Defense Medical College Department of Surgery 3-2 Namiki Tokorozawa 359-8513 JapanHidekazu Sugasawa, National Defense Medical College Department of Surgery 3-2 Namiki Tokorozawa 359-8513 JapanShui...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3224089</comments>
            <pubDate>Thu, 28 Jan 2010 18:05:10 +0100</pubDate>
            <guid isPermaLink="false">3224089</guid>        </item>
        <item>
            <title>Fatty liver disease in children: eat now pay later</title>
            <link>http://www.medworm.com/index.php?rid=3224090&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft04j111291225737%2F</link>
            <description>Abstract
 Introduction&amp;nbsp;&amp;nbsp;With the recent epidemic in childhood obesity, nonalcoholic fatty liver disease (NAFLD) has become an emerging problem and
 a common cause of chronic liver disease in children.
 
 
 
 Methods&amp;nbsp;&amp;nbsp;In this review, the most recent insights on the pathogenesis, diagnosis, natural history, and treatment of NAFLD in children
 are discussed.
 
 
 
	Content Type Journal ArticleCategory Review ArticleDOI 10.1007/s12072-009-9160-zAuthors
		Ruth M. L. De Bruyne, University Hospital Ghent Department of Paediatric Gastroenterology, Hepatology and Nutrition De Pintelaan 185 9000 Ghent BelgiumEmer Fitzpatrick, King’s College Hospital Paediatric Liver, GI and Nutrition Centre, King’s College London School of Medicine London SE59RS UKAnil Dhawan, King’s Colleg...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3224090</comments>
            <pubDate>Thu, 28 Jan 2010 18:05:07 +0100</pubDate>
            <guid isPermaLink="false">3224090</guid>        </item>
        <item>
            <title>Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=3224091&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa764468124u1u46u%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The loss or abnormal protein downregulation and the promoter hypermethylation of RASSF1A could play important roles in the
 tumorigenesis development and metastases of HCC. The detection of the promoter hypermethylation of RASSF1A in serum DNA could
 be a valuable biomarker for early-stage diagnosis in populations at high risk of HCC.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-010-9164-8Authors
		Lang Hu, Guangxi Medical University Department of Epidemiology Nanning 530021 Guangxi Zhuang Autonomous Region People’s Republic of ChinaGang Chen, Guangxi Medical University Department of Pathology Shuangyong Road Nanning 530021 Guangxi Zhuang Autonomous Region People’s Republic of ChinaHongping Yu, Guangxi Medical University Departme...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3224091</comments>
            <pubDate>Thu, 28 Jan 2010 18:05:06 +0100</pubDate>
            <guid isPermaLink="false">3224091</guid>        </item>
        <item>
            <title>Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study</title>
            <link>http://www.medworm.com/index.php?rid=3122799&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2q5004nn44684375%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The data supports the concept of heterogeneity of HCC. The three factors, bilirubin, AFP, and PVT predominate in prognosis.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9157-7Authors
		Brian I. Carr, Thomas Jefferson University Liver Tumor Program, Kimmel Cancer Center Bluemle Building, Room 1002, 233 S. 10th Street Philadelphia 19107 PA USAPetr Pancoska, University of Pittsburgh Center for Clinical Pharmacology Philadelphia USARobert A. Branch, University of Pittsburgh Center for Clinical Pharmacology Philadelphia USA
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3122799</comments>
            <pubDate>Thu, 24 Dec 2009 19:49:31 +0100</pubDate>
            <guid isPermaLink="false">3122799</guid>        </item>
        <item>
            <title>Role of free radicals in liver diseases</title>
            <link>http://www.medworm.com/index.php?rid=3041539&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg125306x138g7488%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Reactive oxygen and nitrogen species (ROS and RNS) are produced by metabolism of normal cells. However, in liver diseases,
 redox is increased thereby damaging the hepatic tissue; the capability of ethanol to increase both ROS/RNS and peroxidation
 of lipids, DNA, and proteins was demonstrated in a variety of systems, cells, and species, including humans. ROS/RNS can activate
 hepatic stellate cells, which are characterized by the enhanced production of extracellular matrix and accelerated proliferation.
 Cross-talk between parenchymal and nonparenchymal cells is one of the most important events in liver injury and fibrogenesis;
 ROS play an important role in fibrogenesis throughout increasing platelet-derived growth factor. Most hepatocellular carcinomas
 occur in cirr...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3041539</comments>
            <pubDate>Thu, 26 Nov 2009 08:15:34 +0100</pubDate>
            <guid isPermaLink="false">3041539</guid>        </item>
        <item>
            <title>Serum α-fetoprotein levels in liver steatosis</title>
            <link>http://www.medworm.com/index.php?rid=2968902&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2735172n448160l0%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Patients with NAFLD have higher AFP levels than those without fatty liver changes. AFP levels rise as grade of liver steatosis
 increases. NAFLD should be among the differential diagnosis of elevated serum AFP levels.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9156-8Authors
		Ayşegül Babalı, Ankara Education and Research Hospital Department of Gastroenterology Ankara TurkeyErman Çakal, Dışkapı Education and Research Hospital Department of Endocrinology Ankara TurkeyTuğrul Purnak, Ankara Numune Education and Research Hospital Department of Gastroenterology Ankara Turkeyİbrahim Bıyıkoğlu, Ankara Education and Research Hospital Department of Gastroenterology Ankara TurkeyBaşak Çakal, Ankara Education and Research Hosp...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2968902</comments>
            <pubDate>Wed, 04 Nov 2009 18:54:34 +0100</pubDate>
            <guid isPermaLink="false">2968902</guid>        </item>
        <item>
            <title>Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis</title>
            <link>http://www.medworm.com/index.php?rid=2921805&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv44436l0243v5236%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;UDCA monotherapy is effective for some Japanese AIH patients; however, UDCA monotherapy for patients with either high-grade
 inflammatory activity or poor residual capacity of liver function is not recommended because they may reach liver failure
 before achievement of remission. Meanwhile, additional use of UDCA during the taper of corticosteroids may be effective for
 the prevention of early relapse.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9155-9Authors
		Yasuhiro Miyake, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Molecular Hepatology Okayama JapanYoshiaki Iwasaki, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Gas...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2921805</comments>
            <pubDate>Wed, 21 Oct 2009 22:21:55 +0100</pubDate>
            <guid isPermaLink="false">2921805</guid>        </item>
        <item>
            <title>CME information</title>
            <link>http://www.medworm.com/index.php?rid=2833377&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa13r0xk225jq8732%2F</link>
            <description>Content Type Journal ArticleCategory CME InformationDOI 10.1007/s12072-009-9152-z

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2833377</comments>
            <pubDate>Tue, 22 Sep 2009 15:41:01 +0100</pubDate>
            <guid isPermaLink="false">2833377</guid>        </item>
        <item>
            <title>CME post test</title>
            <link>http://www.medworm.com/index.php?rid=2833378&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F156g6582r7786w22%2F</link>
            <description>Content Type Journal ArticleCategory CME Post TestDOI 10.1007/s12072-009-9153-y

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2833378</comments>
            <pubDate>Tue, 22 Sep 2009 15:40:59 +0100</pubDate>
            <guid isPermaLink="false">2833378</guid>        </item>
        <item>
            <title>The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=2810984&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhpr1653m07t232j0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Chronic hepatitis B (CHB) remains a serious clinical problem worldwide. Advances in molecular technology have enabled the
 development of sensitive assays for the detection and quantification of hepatitis B virus (HBV) nucleic acid and demonstrated
 a positive correlation between serum HBV DNA levels and disease progression. Assessment of specific serologic and virologic
 factors also plays a pivotal role in the diagnosis and effective management of individuals with CHB. Recent development of
 quantitative assays for intrahepatic HBV replicative intermediates, as well as hepatitis B e antigen and hepatitis B surface
 antigen, has spurred investigation into the relationship between these factors and response to antiviral therapy and disease
 progression. Recent findings ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2810984</comments>
            <pubDate>Fri, 18 Sep 2009 06:48:41 +0100</pubDate>
            <guid isPermaLink="false">2810984</guid>        </item>
        <item>
            <title>Introduction</title>
            <link>http://www.medworm.com/index.php?rid=2810985&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F12601v2qm448185w%2F</link>
            <description>Content Type Journal ArticleCategory Supplement ArticleDOI 10.1007/s12072-009-9154-xAuthors
		Yun-Fan Liaw, Chang Gung Memorial Hospital and University Liver Research Unit 199 Tung Hwa North Road Taipei 105 Taiwan
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2810985</comments>
            <pubDate>Fri, 18 Sep 2009 06:48:40 +0100</pubDate>
            <guid isPermaLink="false">2810985</guid>        </item>
        <item>
            <title>Combined hepatocellular and cholangiocarcinoma with sarcomatoid transformation: radiologic–pathologic correlation of a case</title>
            <link>http://www.medworm.com/index.php?rid=2810986&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv2320123103j16m6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A 71-year-old man presented to our hospital with 3-week history of fever in the background of loss of both weight and appetite
 over the past 3&amp;nbsp;months. He was found to have a large 10-cm mass in the right lobe of the liver on a triple-phase computed
 tomographic scan. The tumor showed a distinct fatty component, with areas of arterial enhancement and venous washout suggestive
 of hepatocellular carcinoma (HCC), another component showing progressive and late enhancement suggestive of cholangiocarcinoma
 (CC), and a third component showing persistent hypoenhancement relative to the liver parenchyma. He underwent surgical resection.
 This was histopathologically a biphasic tumor composed of areas showing hepatocytic differentiation, in contiguity with areas
 showing i...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2810986</comments>
            <pubDate>Thu, 17 Sep 2009 23:29:21 +0100</pubDate>
            <guid isPermaLink="false">2810986</guid>        </item>
        <item>
            <title>Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation</title>
            <link>http://www.medworm.com/index.php?rid=2767431&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft565825454j80531%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The use of NAC causes reduction in NAI-ALF mortality and its use was safe.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9151-0Authors
		Khalid Mumtaz, Aga Khan University Hospital Department of Medicine Karachi PakistanZahid Azam, Aga Khan University Hospital Department of Medicine Karachi PakistanSaeed Hamid, Aga Khan University Hospital Department of Medicine Karachi PakistanShahab Abid, Aga Khan University Hospital Department of Medicine Karachi PakistanSadik Memon, Isra University Hospital Hyderabad PakistanHasnain Ali Shah, Aga Khan University Hospital Department of Medicine Karachi PakistanWasim Jafri, Aga Khan University Hospital Department of Medicine Karachi Pakistan
	

	
		Journal Hepatology InternationalOnline ISSN 193...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2767431</comments>
            <pubDate>Thu, 03 Sep 2009 06:33:52 +0100</pubDate>
            <guid isPermaLink="false">2767431</guid>        </item>
        <item>
            <title>Liver transplantation for acute-on-chronic liver failure</title>
            <link>http://www.medworm.com/index.php?rid=2717853&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq0n68nv8h7m41837%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Liver transplantation for acute-on-chronic liver failure is life-saving, and the survival rates it attains are similar to
 those attained by transplantation for other liver conditions.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9148-8Authors
		Albert C. Chan, The University of Hong Kong Department of Surgery, Queen Mary Hospital 102 Pok Fu Lam Road Hong Kong ChinaSheung Tat Fan, The University of Hong Kong Department of Surgery, Queen Mary Hospital 102 Pok Fu Lam Road Hong Kong ChinaChung Mau Lo, The University of Hong Kong Department of Surgery, Queen Mary Hospital 102 Pok Fu Lam Road Hong Kong ChinaChi Leung Liu, The University of Hong Kong Department of Surgery, Queen Mary Hospital 102 Pok Fu Lam Road Hong Kong ChinaSee Chin...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2717853</comments>
            <pubDate>Tue, 18 Aug 2009 22:04:19 +0100</pubDate>
            <guid isPermaLink="false">2717853</guid>        </item>
        <item>
            <title>Outcomes of patients with chest tube insertion for hepatic hydrothorax</title>
            <link>http://www.medworm.com/index.php?rid=2697569&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F313u028627446878%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Chest tube insertion for hepatic hydrothorax carries significant morbidity and mortality, with questionable benefit.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9136-zAuthors
		Eric S. Orman, University of Michigan Department of Internal Medicine Ann Arbor MI USAAnna S. F. Lok, University of Michigan Health System Division of Gastroenterology 3912 Taubman Center, SPC 5362 Ann Arbor MI USA
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2697569</comments>
            <pubDate>Tue, 11 Aug 2009 08:42:16 +0100</pubDate>
            <guid isPermaLink="false">2697569</guid>        </item>
        <item>
            <title>Dual chronic hepatitis B virus and hepatitis C virus infection</title>
            <link>http://www.medworm.com/index.php?rid=2686213&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg8086332052jq5w6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Dual hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are common in HBV or HCV endemic areas. However, several
 clinical and pathogenetic issues remain unresolved. First, clinical and in vitro studies suggest the interactions between
 two viruses. The dynamics of the interaction in untreated setting versus treated setting and its influence on the long-term
 outcomes await further studies. A key issue regarding viral interactions is whether modulation of infection occurs in the
 same dually infected individual hepatocyte of the liver. Clarifying this issue may help to understand the reciprocal interference
 between HCV and HBV and provide clues for future immunopathogenetic studies. Second, the prevalence and clinical significance
 of coexisting occult HBV i...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2686213</comments>
            <pubDate>Sun, 09 Aug 2009 09:12:38 +0100</pubDate>
            <guid isPermaLink="false">2686213</guid>        </item>
        <item>
            <title>Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas</title>
            <link>http://www.medworm.com/index.php?rid=2683185&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F455t73r604j432l7%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;We successfully highlighted some potential high HCV endemic townships in Taiwan.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9146-xAuthors
		Wei-Wen Su, Changhua Christian Hospital Department of Internal Medicine No. 135 Nanxiao Changhua TaiwanChien-Hung Chen, National Taiwan University Hospital and National Taiwan University College of Medicine Department of Internal Medicine No. 7 Chung San South Rd Taipei TaiwanHans Hsienhong Lin, Buddhist Tzu Chi General Hospital Department of Gastroenterology No. 707, Sec. 3, Chung Yang Rd Hualien TaiwanSheng-Shun Yang, Taichung Veterans General Hospital Department of Internal Medicine No. 160, Sec. 3, Chung-Kang Rd Taichung TaiwanTing-Tsung Chang, National Cheng Kung University Hospital Dep...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2683185</comments>
            <pubDate>Fri, 07 Aug 2009 10:55:04 +0100</pubDate>
            <guid isPermaLink="false">2683185</guid>        </item>
        <item>
            <title>Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C</title>
            <link>http://www.medworm.com/index.php?rid=2680032&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F057158x58j73nn58%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Ultrasound surveillance at 6-month intervals was appropriate in general for the detection of HCC at a size smaller than 30&amp;nbsp;mm.
 However, in patient with established cirrhosis, more frequent screening would be needed to detect tumors of the same size.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9145-yAuthors
		Takahisa Sato, University of Tokyo Department of Gastroenterology 7-3-1 Hongo, Bunkyo-ku Tokyo 113-8655 JapanRyosuke Tateishi, University of Tokyo Department of Gastroenterology 7-3-1 Hongo, Bunkyo-ku Tokyo 113-8655 JapanHaruhiko Yoshida, University of Tokyo Department of Gastroenterology 7-3-1 Hongo, Bunkyo-ku Tokyo 113-8655 JapanTakamasa Ohki, University of Tokyo Department of Gastroenterology 7-3-1 Hongo, Bunkyo-ku ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2680032</comments>
            <pubDate>Thu, 06 Aug 2009 08:32:35 +0100</pubDate>
            <guid isPermaLink="false">2680032</guid>        </item>
        <item>
            <title>On-treatment monitoring of HBV DNA levels: predicting response and resistance to oral antiviral therapy at week 24 versus week 48</title>
            <link>http://www.medworm.com/index.php?rid=2661630&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp302p2g622765217%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The suppression of hepatitis B viral (HBV) load correlates with favorable histologic, biochemical, and serologic responses
 in clinical trials of patients with chronic hepatitis B (CHB). The ability to identify patients who will not experience durable
 viral suppression in response to a specific antiviral regimen affords the opportunity for early treatment modification to
 optimize outcomes and avoid the development of antiviral resistance. Substantial evidence demonstrates that on-treatment serum
 HBV DNA levels are predictive of virologic response and risk of resistance. Regional clinical practice guidelines for the
 management of CHB universally recommend monitoring serum HBV DNA levels at treatment week 24. However, the value of this time
 point as a predictor of lo...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661630</comments>
            <pubDate>Thu, 30 Jul 2009 10:08:08 +0100</pubDate>
            <guid isPermaLink="false">2661630</guid>        </item>
        <item>
            <title>The global burden of iron overload</title>
            <link>http://www.medworm.com/index.php?rid=2661631&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F021712w5646u2683%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There have been major developments in the field of iron metabolism in the past decade following the identification of the
 HFE gene and the mutation responsible for the C282Y substitution in the HFE protein. While HFE-associated hemochromatosis occurs
 predominantly in people of northern European extraction, other less-common mutations can lead to the same clinical syndrome
 and these may occur in other populations in the Asian-Pacific region. The most common of these is the mutation that leads
 to changes in the ferroportin molecule, the protein responsible for the transport of iron across the basolateral membrane
 of the enterocyte and from macrophages. Recent research has unraveled the molecular processes of iron transport and regulation
 of how these are disturbed i...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661631</comments>
            <pubDate>Wed, 29 Jul 2009 07:22:46 +0100</pubDate>
            <guid isPermaLink="false">2661631</guid>        </item>
        <item>
            <title>Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=2592415&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft451336n28628173%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Chinese patients with CHB often carry either B or C genotype. Vietnamese patients with CHB mostly have HBV genotype B. Additional
 studies are needed to further characterize the clinical significance of HBV genotype in the natural history and treatment
 outcomes of CHB in Vietnamese patients.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9141-2Authors
		Long H. Nguyen, Stanford University School of Medicine Stanford CA USANghiem B. Ha, Pacific Health Foundation San Jose CA USAPhilip Vutien, Pacific Health Foundation San Jose CA USANghi B. Ha, Pacific Health Foundation San Jose CA USARuel T. Garcia, Pacific Health Foundation San Jose CA USAHuy N. Trinh, Pacific Health Foundation San Jose CA USABrian S. Levitt, San Jose Gastroentero...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2592415</comments>
            <pubDate>Fri, 10 Jul 2009 08:05:02 +0100</pubDate>
            <guid isPermaLink="false">2592415</guid>        </item>
        <item>
            <title>Chronic hepatitis B in Asian women of childbearing age</title>
            <link>http://www.medworm.com/index.php?rid=2592416&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0278pt7521r52225%2F</link>
            <description>This article reviews
 these issues and highlights areas in which their engagement with public health efforts serves to improve quality of life and
 society as a whole.
 
	Content Type Journal ArticleCategory Supplement ArticleDOI 10.1007/s12072-009-9142-1Authors
		Nancy Leung, Chinese University of Hong Kong Department of Medicine, Alice Ho Miu Ling Nethersole Hospital Room 65, J6, 11 Chuen On Road, Tai Po, NT Hong Kong SAR China
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2592416</comments>
            <pubDate>Thu, 09 Jul 2009 12:02:21 +0100</pubDate>
            <guid isPermaLink="false">2592416</guid>        </item>
        <item>
            <title>Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand</title>
            <link>http://www.medworm.com/index.php?rid=2516101&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft03880026144106w%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Limited access to HBV resistance tests causes physicians in Asia to manage suspected resistance by various HBV DNA assays
 and ALT tests. This raises concerns that resistance may not be detected early enough to be rescued efficiently.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9139-9Authors
		Siwaporn Chainuvati, Mahidol University Department of Medicine, Siriraj Hospital 2 Prannok Road, Bangkok-noi Bangkok 10700 ThailandJun Cheng, Beijing Ditan Hospital No 8, Shundong Jie, Chaoyang District Beijing 100015 ChinaJin Lin Hou, Southern Medical University Hepatology Unit and Department of Infectious Diseases, Institute of Gastroenterology, Nanfang Hospital Guangzhou 510515 Guangdong ChinaChao Wei Hsu, Chang Gung Memorial Hospital a...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2516101</comments>
            <pubDate>Wed, 24 Jun 2009 06:08:33 +0100</pubDate>
            <guid isPermaLink="false">2516101</guid>        </item>
        <item>
            <title>HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=2516102&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr7155p50164u6701%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;During the natural history of chronic hepatitis B virus (HBV) infection, the loss of serum hepatitis B e antigen (HBeAg) and
 the development of anti-HBe antibodies (HBeAg seroconversion) mark a transition from the immune-active phase of disease to
 the inactive carrier state. This review examines the evidence from natural history and cohort studies on the relationship
 between HBeAg seroconversion and disease progression. The role of HBeAg seroconversion as an important milestone in the management
 of HBeAg-positive patients with chronic hepatitis B (CHB), as well as the advantages and disadvantages of administering a
 finite course of therapy for HBeAg-positive CHB, is also discussed. The evidence from natural history and cohort studies indicates
 that spontaneous or ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2516102</comments>
            <pubDate>Wed, 24 Jun 2009 06:08:31 +0100</pubDate>
            <guid isPermaLink="false">2516102</guid>        </item>
        <item>
            <title>The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression</title>
            <link>http://www.medworm.com/index.php?rid=2490824&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F64w7829018654044%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Hepatocellular cholesterol metabolism was at least partially disturbed, even in the early stage of PBC. The most characteristic
 finding was a distinct elevation of MDR3 expression, and the MDR3 levels were negatively correlated with GGT and IgM levels.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9137-yAuthors
		Munechika Enjoji, Fukuoka University Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences 8-19-1 Nanakuma, Jonan-ku Fukuoka 814-0180 JapanRyoko Yada, National Hospital Organization Clinical Research Center, Kyushu Medical Center Fukuoka JapanTatsuya Fujino, National Hospital Organization Clinical Research Center, Kyushu Medical Center Fukuoka JapanTsuyoshi Yoshimoto, National Hospital Organization Depa...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2490824</comments>
            <pubDate>Wed, 17 Jun 2009 07:11:38 +0100</pubDate>
            <guid isPermaLink="false">2490824</guid>        </item>
        <item>
            <title>The saga of entecavir</title>
            <link>http://www.medworm.com/index.php?rid=2490825&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fwt7591335m7524l7%2F</link>
            <description>Content Type Journal ArticleCategory EditorialDOI 10.1007/s12072-009-9138-xAuthors
		Ching-Lung Lai, The University of Hong Kong Department of Medicine Queen Mary Hospital, Pokfulam Hong Kong ChinaMan-Fung Yuen, The University of Hong Kong Department of Medicine Queen Mary Hospital, Pokfulam Hong Kong China
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2490825</comments>
            <pubDate>Wed, 17 Jun 2009 07:11:37 +0100</pubDate>
            <guid isPermaLink="false">2490825</guid>        </item>
        <item>
            <title>Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial</title>
            <link>http://www.medworm.com/index.php?rid=2434443&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn43145354k211829%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Entecavir 0.01–0.5&amp;nbsp;mg is well tolerated and produces a dose-dependent reduction in viral load in nucleoside-naive Japanese
 patients with CHB. Compared with lamivudine 100&amp;nbsp;mg, entecavir 0.1&amp;nbsp;mg demonstrated noninferiority and entecavir 0.5&amp;nbsp;mg was
 superior in this population.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9135-0Authors
		Michiko Shindo, Akashi Municipal Hospital Division of Liver Disease, Department of Internal Medicine 1-33 Takasyo-machi, Akashi-shi Hyogo JapanKazuaki Chayama, Hiroshima University Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences Hiroshima JapanSatoshi Mochida, Saitama Medical University Department of Gastroenterology and Hepatology Saitama Ja...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2434443</comments>
            <pubDate>Sun, 24 May 2009 06:11:02 +0100</pubDate>
            <guid isPermaLink="false">2434443</guid>        </item>
        <item>
            <title>A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan</title>
            <link>http://www.medworm.com/index.php?rid=2432814&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe24m6678xn821177%2F</link>
            <description>In conclusion, in patients infected with HCV genotype 2 and pretreatment viral load below 1000&amp;nbsp;kIU/ml who achieve
 RVR, 24-week treatment with peginterferon α-2a alone is clinically sufficient. Those who show no RVR or have higher baseline
 viral load, require alternative therapies.
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9134-1Authors
		Yoshiaki Iwasaki, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Department of Gastroenterology and Hepatology 2-5-1, Shikata-cho Okayama 700-8558 JapanYasushi Shiratori, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Department of Gastroenterology and Hepatology 2-5-1, Shikata-cho Okayama 700-8558 JapanShuhei Hige, Hokkaido Universi...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2432814</comments>
            <pubDate>Fri, 22 May 2009 05:46:07 +0100</pubDate>
            <guid isPermaLink="false">2432814</guid>        </item>
        <item>
            <title>Natural history of hepatic vena cava disease, the liver disease due to obstruction of the hepatic portion of inferior vena cava</title>
            <link>http://www.medworm.com/index.php?rid=2400552&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F666n160u58737272%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Natural history and management of HVD was different from hepatic vein thrombosis caused by hypercoagulable condition, a disease
 with which it is commonly grouped together under Budd-Chiari syndrome.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9133-2Authors
		Santosh Man Shrestha, Liver Foundation Nepal Sitapaela Height P.O. Box No. 3439 Kathmandu Nepal
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2400552</comments>
            <pubDate>Fri, 08 May 2009 05:57:17 +0100</pubDate>
            <guid isPermaLink="false">2400552</guid>        </item>
        <item>
            <title>A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2400553&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmrk2860244223505%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In patients with unresectable HCC, TACE&amp;nbsp;+&amp;nbsp;thymalfasin resulted in numerically higher rates of survival and tumor response,
 including transplant candidacy, with fewer bacterial infections, than TACE alone. Treatment regimens for HCC including thymalfasin
 as an immunomodulator should be evaluated in larger trials.
 
 
 
	Content Type Journal ArticleCategory Original articleDOI 10.1007/s12072-009-9132-3Authors
		Robert G. Gish, California Pacific Medical Center Department of Hepatology and Complex Gastroenterology 2340 Clay St. #233 San Francisco CA 94115 USAStuart C. Gordon, Henry Ford Health System Division of Hepatology 2799 West Grand Boulevard Detroit MI 48202-2689 USADavid Nelson, University of Florida College of Medicine Section of Hepatology and Live...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2400553</comments>
            <pubDate>Fri, 08 May 2009 05:57:16 +0100</pubDate>
            <guid isPermaLink="false">2400553</guid>        </item>
        <item>
            <title>Cerebral embolism following N-butyl-2-cyanoacrylate injection for esophageal postbanding ulcer bleed: a case report</title>
            <link>http://www.medworm.com/index.php?rid=2400554&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F382p114l818705ju%2F</link>
            <description>We report a case of cerebral
 embolism a few hours after an injection of Histoacryl into a bleeding esophageal post-banding ulcer. Echocardiogram revealed
 patent foramen ovale.
 
	Content Type Journal ArticleCategory Case ReportDOI 10.1007/s12072-009-9130-5Authors
		Asmarani Abdullah, Selayang Hospital Hepatology Unit Lebohraya Selayang-Kepong 68100 Batu Caves Selangor MalaysiaSharmila Sachithanandan, Selayang Hospital Hepatology Unit Lebohraya Selayang-Kepong 68100 Batu Caves Selangor MalaysiaOoi Keat Tan, Selayang Hospital Hepatology Unit Lebohraya Selayang-Kepong 68100 Batu Caves Selangor MalaysiaYee Ming Chan, Selayang Hospital Hepatology Unit Lebohraya Selayang-Kepong 68100 Batu Caves Selangor MalaysiaDennise Khoo, Selayang Hospital Hepatology Unit Lebohraya Selayang-Kepong 68100 Bat...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2400554</comments>
            <pubDate>Wed, 06 May 2009 05:55:38 +0100</pubDate>
            <guid isPermaLink="false">2400554</guid>        </item>
        <item>
            <title>Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=2384186&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk0710140075170l4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Two patients developed segmental, diffuse intrahepatic recurrence after percutaneous radiofrequency ablation (RFA) to treat
 a primary, solitary, and small (2.5&amp;nbsp;cm) hepatocellular carcinoma (HCC). Despite the size of the HCC, levels of the tumor markers
 (α-fetoprotein, α-fetoprotein-L3%, and des-γ-carboxyprothrombin) were all elevated before RFA, and tumors in both patients
 were contiguous with a major branch of the portal vein. Tumor biopsies of both patients revealed moderately differentiated
 HCC but diagnostic imaging showed an area of reduced tumor blood flow, suggesting a poorly differentiated component. Since
 early detection of post-RFA malignancies by standard ultrasonography and contrast-enhanced computed tomography was difficult,
 the most sensitive...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2384186</comments>
            <pubDate>Thu, 30 Apr 2009 06:07:29 +0100</pubDate>
            <guid isPermaLink="false">2384186</guid>        </item>
        <item>
            <title>Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cells</title>
            <link>http://www.medworm.com/index.php?rid=2357836&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq5803h273175u108%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Inhibition of the proliferation of hepatic stellate cells (HSC) is clinically important for the control of liver fibrosis
 and cirrhosis. Interferons are now frequently used for chronic viral hepatitis because of their anti-viral activity. However,
 patients treated with interferons exhibit a regression of liver fibrosis even if viral eradication is not achieved, indicating
 that interferon itself has anti-fibrotic activity. Herein, we show the anti-proliferation and pro-apoptotic activity of natural
 interferon α against HSC. We found that interferon α inhibited serum-stimulated [3H]thymidine incorporation of HSC in a dose-dependent manner, with a significant reduction at more than 100&amp;nbsp;U/ml. Interferon
 α also attenuated PDGF-BB-stimulated DNA synthesis of HSC....</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2357836</comments>
            <pubDate>Tue, 21 Apr 2009 10:57:52 +0100</pubDate>
            <guid isPermaLink="false">2357836</guid>        </item>
        <item>
            <title>Well-differentiated hepatocellular carcinoma smaller than 15 mm in diameter totally eradicated with percutaneous ethanol injection instead of radiofrequency ablation</title>
            <link>http://www.medworm.com/index.php?rid=3098250&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl08h605237358321%2F</link>
            <description>We describe three cases of well-differentiated hepatocellular carcinoma (HCC) smaller than 15&amp;nbsp;mm in diameter completely eradicated
 with percutaneous ethanol injection (PEI) instead of using radiofrequency ablation (RFA). Ultrasound (US) examination revealed
 one nodule each in segment 2 (hypoechoic, near bile ducts, 10&amp;nbsp;mm), in segment 5 (hyperechoic, near the gall bladder, 15&amp;nbsp;mm),
 and in segment 7 (hypoechoic, near the diaphragm, 15&amp;nbsp;mm). Although imaging studies revealed isovascular (case 1) and hypervascular
 (cases 2 and 3) nodules, histological analysis of US-guided biopsy tissue revealed well-differentiated HCC. In consideration
 of the location of the nodules, PEI, instead of RFA, was administered and the nodules were rendered necrotic. Although RFA
 is superior ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3098250</comments>
            <pubDate>Sat, 21 Mar 2009 09:05:21 +0100</pubDate>
            <guid isPermaLink="false">3098250</guid>        </item>
        <item>
            <title>Well-differentiated hepatocellular carcinoma smaller than 15 mm in diameter totally eradicated with percutaneous ethanol injection instead of radiofrequency ablation</title>
            <link>http://www.medworm.com/index.php?rid=2288677&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl08h605237358321%2F</link>
            <description>We describe three cases of well-differentiated hepatocellular carcinoma (HCC) smaller than 15&amp;nbsp;mm in diameter completely eradicated
 with percutaneous ethanol injection (PEI) instead of using radiofrequency ablation (RFA). Ultrasound (US) examination revealed
 one nodule each in segment 2 (hypoechoic, near bile ducts, 10&amp;nbsp;mm), in segment 5 (hyperechoic, near the gall bladder, 15&amp;nbsp;mm),
 and in segment 7 (hypoechoic, near the diaphragm, 15&amp;nbsp;mm). Although imaging studies revealed isovascular (case 1) and hypervascular
 (cases 2 and 3) nodules, histological analysis of US-guided biopsy tissue revealed well-differentiated HCC. In consideration
 of the location of the nodules, PEI, instead of RFA, was administered and the nodules were rendered necrotic. Although RFA
 is superior ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2288677</comments>
            <pubDate>Sat, 21 Mar 2009 09:05:21 +0100</pubDate>
            <guid isPermaLink="false">2288677</guid>        </item>
        <item>
            <title>Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients</title>
            <link>http://www.medworm.com/index.php?rid=2277756&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F916k83567256088u%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;IL-18 promoter polymorphism at −607 position with A/A allele is a potential protective marker, as it is associated with milder
 liver disease in patients with chronic HCV infection.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9127-0Authors
		K. Manohar, G.B. Pant Hospital Department of Gastroenterology New Delhi IndiaP. V. Suneetha, G.B. Pant Hospital Department of Gastroenterology New Delhi IndiaSukriti, G.B. Pant Hospital Department of Gastroenterology New Delhi IndiaNirupama Trehan Pati, G.B. Pant Hospital Department of Gastroenterology New Delhi IndiaAbhishek C. Gupta, G.B. Pant Hospital Department of Gastroenterology New Delhi IndiaSyed Hissar, G.B. Pant Hospital Department of Gastroenterology New Delhi IndiaPuja Sakhuja,...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2277756</comments>
            <pubDate>Tue, 17 Mar 2009 07:08:16 +0100</pubDate>
            <guid isPermaLink="false">2277756</guid>        </item>
        <item>
            <title>Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization</title>
            <link>http://www.medworm.com/index.php?rid=2240645&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3307013x44153967%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hepatocellular adenoma is a rare benign tumor of the liver. However, some complications, such as hemorrhage, rupture, and
 malignant transformation, have been reported previously. Surgical resection is considered to be the best choice of treatment,
 when adenomas are increasing in size, while resection is difficult to perform when multiple adenomas develop throughout the
 liver. Here, we report two cases of multiple hepatocellular adenomatosis. One patient had a history of aplastic anemia and
 the other had glycogen storage disease. We treated them with transcatheter arterial embolization (TAE) to prevent hemorrhage
 and rupture. After TAE, most parts of the adenomas showed necrotic change. These cases suggest that TAE is an effective treatment
 of hepatocellular adenom...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2240645</comments>
            <pubDate>Thu, 05 Mar 2009 12:30:04 +0100</pubDate>
            <guid isPermaLink="false">2240645</guid>        </item>
        <item>
            <title>Usjmscp-Nih-Apasl</title>
            <link>http://www.medworm.com/index.php?rid=2152847&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw57xj6q330238g07%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-009-9124-3

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2152847</comments>
            <pubDate>Sat, 31 Jan 2009 07:35:19 +0100</pubDate>
            <guid isPermaLink="false">2152847</guid>        </item>
        <item>
            <title>Author Index</title>
            <link>http://www.medworm.com/index.php?rid=2152849&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd7525421707832np%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-009-9125-2

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2152849</comments>
            <pubDate>Sat, 31 Jan 2009 07:35:18 +0100</pubDate>
            <guid isPermaLink="false">2152849</guid>        </item>
        <item>
            <title>Poster Exhibition</title>
            <link>http://www.medworm.com/index.php?rid=2152848&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm1w2467r8g12850r%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-009-9123-4

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2152848</comments>
            <pubDate>Sat, 31 Jan 2009 07:35:18 +0100</pubDate>
            <guid isPermaLink="false">2152848</guid>        </item>
        <item>
            <title>Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava</title>
            <link>http://www.medworm.com/index.php?rid=2131272&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj6w026l800708342%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;HVD is independent risk factors for LC and HCC. Severe and/or recurrent loss of hepatocytes caused by hepatic venous outflow
 obstruction and/or thrombotic obstruction of small radicals of hepatic and portal veins that occurred during acute exacerbations
 was considered important in the pathogenesis of LC and HCC in HVD.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-009-9122-5Authors
		Santosh Man Shrestha, Liver Foundation Nepal Sitapaela Height P.O. Box 3439 Kathmandu Nepal
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2131272</comments>
            <pubDate>Fri, 23 Jan 2009 09:39:56 +0100</pubDate>
            <guid isPermaLink="false">2131272</guid>        </item>
        <item>
            <title>Free Paper Presentation</title>
            <link>http://www.medworm.com/index.php?rid=2131273&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa65413518m176104%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-008-9121-y

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2131273</comments>
            <pubDate>Fri, 23 Jan 2009 09:39:52 +0100</pubDate>
            <guid isPermaLink="false">2131273</guid>        </item>
        <item>
            <title>Plenary Presentation</title>
            <link>http://www.medworm.com/index.php?rid=2128818&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh57160722q261058%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-008-9118-6

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2128818</comments>
            <pubDate>Thu, 22 Jan 2009 00:11:46 +0100</pubDate>
            <guid isPermaLink="false">2128818</guid>        </item>
        <item>
            <title>Invited Abstract: 19th Conference of the Asian Pacific Association for the Study of the Liver</title>
            <link>http://www.medworm.com/index.php?rid=2128821&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fgp55468501063394%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-008-9119-5

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2128821</comments>
            <pubDate>Thu, 22 Jan 2009 00:11:45 +0100</pubDate>
            <guid isPermaLink="false">2128821</guid>        </item>
        <item>
            <title>Young Investigator Presentation</title>
            <link>http://www.medworm.com/index.php?rid=2128820&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqx0124581r174w57%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-008-9117-7

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2128820</comments>
            <pubDate>Thu, 22 Jan 2009 00:11:45 +0100</pubDate>
            <guid isPermaLink="false">2128820</guid>        </item>
        <item>
            <title>Poster Presentation</title>
            <link>http://www.medworm.com/index.php?rid=2128819&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F11n87x8544677043%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-008-9120-z

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2128819</comments>
            <pubDate>Thu, 22 Jan 2009 00:11:45 +0100</pubDate>
            <guid isPermaLink="false">2128819</guid>        </item>
        <item>
            <title>Hepatitis A outbreaks in China during 2006: application of molecular epidemiology</title>
            <link>http://www.medworm.com/index.php?rid=2055781&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd49jq42518787683%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Contaminated water and suspected ice cream were associated with outbreaks of hepatitis A. Viral genetic analysis may advance
 field investigations in complex situations.
 
 
 
	Content Type Journal ArticleCategory ORIGINAL ARTICLEDOI 10.1007/s12072-008-9116-8Authors
		Jingyuan Cao, Chinese Center for Disease Control and Prevention Division of Hepatitis, National Institute for Viral Disease Control and Prevention Yingxin Street 100, Xuanwu District Beijing 100052 People’s Republic of ChinaYue Wang, Chinese Center for Disease Control and Prevention Division of Hepatitis, National Institute for Viral Disease Control and Prevention Yingxin Street 100, Xuanwu District Beijing 100052 People’s Republic of ChinaHaiyan Song, Harbin Medical University Second Hospital Depart...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2055781</comments>
            <pubDate>Fri, 19 Dec 2008 08:21:09 +0100</pubDate>
            <guid isPermaLink="false">2055781</guid>        </item>
        <item>
            <title>A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=2055782&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv2h5816310836610%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To address the relationship between hepatitis B virus (HBV) endemicity and HBV-related liver diseases in Mexico. Research
 literature reporting on HBsAg and antibody to hepatitis B core antigen (anti-HBc) prevalence in Mexican study groups were
 searched in NLM Gateway, PubMed, IMBIOMED, and others. Weighted mean prevalence (WMP) was calculated from the results of each
 study group. A total of 50 studies were analyzed. Three nationwide surveys revealed an HBsAg seroprevalence of less than 0.3%.
 Horizontal transmission of HBV infection occurred mainly by sexual activity and exposure to both contaminated surgical equipment
 and body fluids. High-risk groups exposed to these factors included healthcare workers, pregnant women, female sex workers,
 hemodialysis patients, a...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2055782</comments>
            <pubDate>Fri, 19 Dec 2008 08:21:08 +0100</pubDate>
            <guid isPermaLink="false">2055782</guid>        </item>
        <item>
            <title>Induction of tropomyosin during hepatic stellate cell activation and the progression of liver fibrosis</title>
            <link>http://www.medworm.com/index.php?rid=2033003&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F015572731502117t%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The activation of hepatic stellate cells (HSCs) is a cue to initiate liver fibrosis. Activated stellate cells acquire contractile
 activity similar to pericytes and myofibroblasts in other organs by inducing the contractile machinery of cytoskeletons such
 as smooth muscle α-actin (α-SMA), a well-known marker of activated stellate cells, and actin-binding proteins. We further
 show herein the expression of tropomyosin in rat HSCs in the course of their activation during primary culture and liver tissue
 damaged by thioacetamide intoxication. In immunoblot analysis, tropomyosin became detectable in an early stage of the primary
 culture of rat stellate cells in a manner similar to the expression of α-SMA and platelet-derived growth factor receptor-β.
 Tropomyosin was...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033003</comments>
            <pubDate>Thu, 11 Dec 2008 12:15:52 +0100</pubDate>
            <guid isPermaLink="false">2033003</guid>        </item>
        <item>
            <title>Systemic and pulmonary hemodynamics in patients with extrahepatic portal vein obstruction is similar to compensated cirrhotic patients</title>
            <link>http://www.medworm.com/index.php?rid=2033004&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx6176676552510m1%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;EHPVO patients have hyperdynamic circulation manifested by high cardiac index and low systemic and pulmonary vascular resistance
 indices. These hemodynamic changes are comparable with compensated cirrhotic patients who have similar grade of portal hypertension.
 This suggests a predominant role of portal hypertension per se in the genesis of systemic and pulmonary hemodynamic alterations.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9110-1Authors
		Sanjeev Kumar Jha, Affiliated to University of Delhi Department of Gastroenterology, G B Pant Hospital Room 201, Academic Block New Delhi 110 002 IndiaAshish Kumar, Affiliated to University of Delhi Department of Gastroenterology, G B Pant Hospital Room 201, Academic Block New Delhi 1...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033004</comments>
            <pubDate>Wed, 10 Dec 2008 07:40:39 +0100</pubDate>
            <guid isPermaLink="false">2033004</guid>        </item>
        <item>
            <title>Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=2033005&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn561v2124k2774w2%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;ETVr emerged in two Japanese nucleoside-naive CHB patients after prolonged therapy and incomplete suppression and in one patient
 after &amp;lt;0.5&amp;nbsp;mg of dosing. ETV patients with detectable HBV DNA or breakthrough after extended therapy should be evaluated for
 compliance to therapy and potential emergence of resistance.
 
 
 
	Content Type Journal ArticleCategory Case ReportDOI 10.1007/s12072-008-9108-8Authors
		Haruhiko Kobashi, Okayama University Department of Gastroenterology and Hepatology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Okayama JapanShin-ichi Fujioka, Okayama Saiseikai General Hospital Department of Medicine Okayama JapanMitsuhiko Kawaguchi, Okayama Saiseikai General Hospital Department of Medicine Okayama JapanHiromitsu K...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2033005</comments>
            <pubDate>Wed, 10 Dec 2008 07:40:38 +0100</pubDate>
            <guid isPermaLink="false">2033005</guid>        </item>
        <item>
            <title>Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)</title>
            <link>http://www.medworm.com/index.php?rid=2017462&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F085613458702736k%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Liver fibrosis is a common pathway leading to cirrhosis, which is the final result of injury to the liver. Accurate assessment
 of the degree of fibrosis is important clinically, especially when treatments aimed at reversing fibrosis are being evolved.
 Liver biopsy has been considered to be the “gold standard” to assess fibrosis. However, liver biopsy being invasive and, in
 many instances, not favored by patients or physicians, alternative approaches to assess liver fibrosis have assumed great
 importance. Moreover, therapies aimed at reversing the liver fibrosis have also been tried lately with variable results. Till
 now, there has been no consensus on various clinical, pathological, and radiological aspects of liver fibrosis. The Asian
 Pacific Association for ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2017462</comments>
            <pubDate>Thu, 04 Dec 2008 06:56:48 +0100</pubDate>
            <guid isPermaLink="false">2017462</guid>        </item>
        <item>
            <title>High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection</title>
            <link>http://www.medworm.com/index.php?rid=2011005&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa0k77675x7466275%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our findings suggest that HBV infection itself does not affect adiponectin levels. Serum adiponectin level correlates with
 the progression of HBV-related liver diseases but not with the development of HBeAg SC.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9111-0Authors
		Chun-Jen Liu, National Taiwan University College of Medicine, National Taiwan University Hospital Graduate Institute of Clinical Medicine No. 7, Chung-Shan South Road Taipei 10002 TaiwanPei-Jer Chen, National Taiwan University College of Medicine, National Taiwan University Hospital Graduate Institute of Clinical Medicine No. 7, Chung-Shan South Road Taipei 10002 TaiwanMing-Yang Lai, National Taiwan University College of Medicine, National Taiwan University Hosp...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2011005</comments>
            <pubDate>Tue, 02 Dec 2008 07:36:15 +0100</pubDate>
            <guid isPermaLink="false">2011005</guid>        </item>
        <item>
            <title>The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=1996214&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3828566682040307%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Studies to date suggest that HBV genotypes/subgenotypes have important influences on the outcome of chronic HBV infection,
 but more population-based prospective studies examining multiple genotypes are needed.
 
 
 
	Content Type Journal ArticleCategory Review ArticleDOI 10.1007/s12072-008-9112-zAuthors
		Brian J. McMahon, Alaska Native Tribal Health Consortium; and Arctic Investigations Program, Centers for Disease Control and Prevention Liver Disease and Hepatitis Program 4315 Diplomacy Drive Anchorage AK 99508 USA
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1996214</comments>
            <pubDate>Wed, 26 Nov 2008 20:04:24 +0100</pubDate>
            <guid isPermaLink="false">1996214</guid>        </item>
        <item>
            <title>Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)</title>
            <link>http://www.medworm.com/index.php?rid=1980532&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg0627470564r1008%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The Asian Pacific Association for the Study of the Liver (APASL) set up a working party on acute-on-chronic liver failure
 (ACLF) in 2004, with a mandate to develop consensus guidelines on various aspects of ACLF relevant to disease patterns and
 clinical practice in the Asia-Pacific region. Experts predominantly from the Asia–Pacific region constituted this working
 party and were requested to identify different issues of ACLF and develop the consensus guidelines. A 2-day meeting of the
 working party was held on January 22–23, 2008, at New Delhi, India, to discuss and finalize the consensus statements. Only
 those statements that were unanimously approved by the experts were accepted. These statements were circulated to all the
 experts and subsequently presented ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1980532</comments>
            <pubDate>Thu, 20 Nov 2008 08:14:00 +0100</pubDate>
            <guid isPermaLink="false">1980532</guid>        </item>
        <item>
            <title>Histological features of early hepatocellular carcinomas and their developmental process: for daily practical clinical application</title>
            <link>http://www.medworm.com/index.php?rid=1963889&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg07u03u81317g8qt%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Based on clinical and pathological experience, indistinct margin-type hepatocellular carcinomas (HCCs) were considered to
 be typical early-stage HCCs with good prognosis. For histological diagnosis, the assessment of stromal invasion (tumor invasion
 into portal tracts and fibrous septa) is very important. In differentiating stromal invasion from pseudoinvasion (benign hepatic
 tissue in the fibrous stroma), the following 5 items are useful: (1) macroscopic or panoramic views of the histological specimen,
 (2) amount of fibrous components of the stroma, (3) destruction of the structure of portal tracts, (4) loss of reticulin fibers
 around cancer cells, and (5) cytokeratin 7 immunostaining for ductular proliferation. Parenchymal features of early HCCs are
 summarized a...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1963889</comments>
            <pubDate>Fri, 14 Nov 2008 08:04:48 +0100</pubDate>
            <guid isPermaLink="false">1963889</guid>        </item>
        <item>
            <title>Cirrhotic cardiomyopathy</title>
            <link>http://www.medworm.com/index.php?rid=1955159&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk732065865731706%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cirrhotic cardiomyopathy is a recently recognized condition in cirrhosis consisting of systolic incompetence under condition
 of stress, diastolic dysfunction related to altered diastolic relaxation, and electrophysiological abnormalities in the absence
 of any known cardiac disease. It can be diagnosed by using a combination of electrocardiograph, 2-dimensional echocardiography,
 and various serum markers such as brain natriuretic factor. The underlying pathogenetic mechanisms include abnormalities in
 the β-adrenergic signaling pathway, altered cardiomyocyte membrane fluidity, increased myocardial fibrosis, cardiomyocyte
 hypertrophy, and ion channel defects. Various compounds for which levels are elevated in cirrhosis such as nitric oxide and
 carbon monoxide can al...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1955159</comments>
            <pubDate>Tue, 11 Nov 2008 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">1955159</guid>        </item>
        <item>
            <title>A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=1901336&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj5048877t605460k%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;It is important when comparing resistance rates to antiviral drugs in CHB to consider the methodology and definition of resistance
 used because this can dramatically influence the results.
 
 
 
	Content Type Journal ArticleCategory Review ArticleDOI 10.1007/s12072-008-9105-yAuthors
		Hie-Won Hann, Jefferson Medical College Division of Gastroenterology and Hepatology, Department of Medicine 1025 Walnut Street Philadelphia PA 19107 USAVicki L. Gregory, Writeology 19 Riddy Lane, Bourn Cambridge CB23 2SP UKJonathan S. Dixon, GlaxoSmithKline 980 Great West Road Brentford, Middlesex TW8 9GS UKKeith F. Barker, GlaxoSmithKline 980 Great West Road Brentford, Middlesex TW8 9GS UK
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepato...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1901336</comments>
            <pubDate>Tue, 21 Oct 2008 05:55:41 +0100</pubDate>
            <guid isPermaLink="false">1901336</guid>        </item>
        <item>
            <title>The influence of preconditioning on metabolic changes in the pig liver before, during, and after warm liver ischemia measured by microdialysis</title>
            <link>http://www.medworm.com/index.php?rid=1883260&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F82308027h9465502%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The present study demonstrated profound metabolic changes before, during, and after warm liver ischemia under the influence
 of IPC. Compared with a similar study without IPC, the metabolic changes seem to be unaffected by preconditioning.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9104-zAuthors
		Anne-Sofie Kannerup, Aarhus University Hospital Department of Surgical Gastroenterology L 8000 Aarhus C DenmarkHenning Grønbæk, Aarhus University Hospital Department of Medical Gastroenterology V 8000 Aarhus C DenmarkPeter Funch-Jensen, Aarhus University Hospital Department of Surgical Gastroenterology L 8000 Aarhus C DenmarkRasmus Langelund Jørgensen, Aarhus University Hospital Department of Surgical Gastroenterology L 8000 Aarhus...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1883260</comments>
            <pubDate>Wed, 15 Oct 2008 10:52:42 +0100</pubDate>
            <guid isPermaLink="false">1883260</guid>        </item>
        <item>
            <title>Seroepidemiology of hepatitis B virus infection: analysis of mass screening in Hawaii</title>
            <link>http://www.medworm.com/index.php?rid=1883259&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq7x566p230374572%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This study furthers current knowledge of HBV epidemiology in areas with large populations of high-risk immigrants and demonstrates
 the relevance of screening programs for hepatitis B.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9103-0Authors
		Naoky C. S. Tsai, Hawaii Medical Center Liver Center 2230 Liliha Street, 2MA Honolulu HI 96817 USAPeter S. Holck, University of Hawaii at Manoa Department of Public Health Sciences, John A. Burns School of Medicine 1960 East-West Road, Biomed D204 Honolulu HI 96822 USALinda L. Wong, University of Hawaii at Manoa Department of Surgery, John A. Burns School of Medicine 1356 Lusitana Street, 6th Floor Honolulu HI 96813 USAAldrich A. Ricalde, Hawaii Medical Center Liver Center 2230 Liliha Str...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1883259</comments>
            <pubDate>Wed, 15 Oct 2008 10:52:42 +0100</pubDate>
            <guid isPermaLink="false">1883259</guid>        </item>
        <item>
            <title>Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy</title>
            <link>http://www.medworm.com/index.php?rid=1850919&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9664l33q6hg64802%2F</link>
            <description>We describe a case of
 activation of chronic hepatitis B infection associated with imatinib therapy.
 
	Content Type Journal ArticleCategory Case ReportDOI 10.1007/s12072-008-9099-5Authors
		Shilen Lakhani, Georgetown University School of Medicine Section of Gastroenterology and Hepatology, Washington Hospital Center 110 Irving Street NW Washington DC 20010 USALev Davidson, Georgetown University School of Medicine Washington Cancer Institute, Washington Hospital Center 110 Irving Street NW Washington DC 20010 USADennis A. Priebat, Georgetown University School of Medicine Washington Cancer Institute, Washington Hospital Center 110 Irving Street NW Washington DC 20010 USAAverell H. Sherker, Georgetown University School of Medicine Section of Gastroenterology and Hepatology, Washington Hospit...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1850919</comments>
            <pubDate>Thu, 02 Oct 2008 09:29:02 +0100</pubDate>
            <guid isPermaLink="false">1850919</guid>        </item>
        <item>
            <title>A case of lamivudine-sensitive de novo acute hepatitis B induced by rituximab with the CHOP regimen for diffuse large B cell lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=1825435&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb806775804043448%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A case of de&amp;nbsp;novo acute hepatitis B that showed symptoms of general malaise and anorexia during rituximab therapy with the
 CHOP regimen for diffuse large B cell lymphoma is reported. Lamivudine was strikingly effective, showing a rapid recovery
 from liver damage with jaundice. Hepatitis B virus (HBV) DNA in serum became and stayed undetectable even after the withdrawal
 of lamivudine, although HBsAg remained positive over 42&amp;nbsp;months from the onset. Liver biopsy showed a picture suggestive of
 acute viral hepatitis with multinucleated giant hepatocytes and CD38-positive plasma cell infiltration into liver parenchyma.
 Immunohistochemically, CD3-positive T-cells were predominant cells that infiltrated in liver parenchyma, whereas CD20-positive
 B cells were ess...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1825435</comments>
            <pubDate>Tue, 23 Sep 2008 10:23:32 +0100</pubDate>
            <guid isPermaLink="false">1825435</guid>        </item>
        <item>
            <title>Relation of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels to growth retardation in extrahepatic portal vein obstruction</title>
            <link>http://www.medworm.com/index.php?rid=1815202&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9325q682nq127278%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Growth retardation by anthropometry was documented in a quarter of patients with EHPVO. All patients had significantly low
 IGF-1 and IGFBP-3 levels in comparison with controls despite normal anthropometry in majority of patients (75%).
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9102-1Authors
		Lalit Nihal, Seth GS Medical College and KEM Hospital Department of Gastroenterology Parel Mumbai 400 012 Maharashtra IndiaMukta R. Bapat, Seth GS Medical College and KEM Hospital Department of Gastroenterology Parel Mumbai 400 012 Maharashtra IndiaPravin Rathi, Seth GS Medical College and KEM Hospital Department of Gastroenterology Parel Mumbai 400 012 Maharashtra IndiaNalini S. Shah, Seth GS Medical College and KEM Hospital Department ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1815202</comments>
            <pubDate>Sat, 20 Sep 2008 09:56:04 +0100</pubDate>
            <guid isPermaLink="false">1815202</guid>        </item>
        <item>
            <title>APASL Seoul 2008 Meeting</title>
            <link>http://www.medworm.com/index.php?rid=1815201&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr5vt506828h84mt2%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-008-9101-2

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1815201</comments>
            <pubDate>Sat, 20 Sep 2008 09:56:04 +0100</pubDate>
            <guid isPermaLink="false">1815201</guid>        </item>
        <item>
            <title>Pathogenetic background for treatment of ascites and hepatorenal syndrome</title>
            <link>http://www.medworm.com/index.php?rid=1815203&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq7030264u3445l09%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ascites and hepatorenal syndrome (HRS) are the major and challenging complications of cirrhosis and portal hypertension that
 significantly affect the course of the disease. Liver insufficiency, portal hypertension, arterial vasodilatation, and systemic
 cardiovascular dysfunction are major pathophysiological hallmarks. Modern treatment of ascites is based on this recognition
 and includes modest salt restriction and stepwise diuretic therapy with spironolactone and loop diuretics. Tense and refractory
 ascites should be treated with a large volume paracentesis, followed by volume expansion or transjugular intrahepatic portosystemic
 shunt. New treatment strategies include the use of vasopressin V2-receptor antagonists and vasoconstrictors. The HRS denotes a functional ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1815203</comments>
            <pubDate>Sat, 20 Sep 2008 09:56:02 +0100</pubDate>
            <guid isPermaLink="false">1815203</guid>        </item>
        <item>
            <title>A 7-day profile of oxidative stress and antioxidant status in patients with acute liver failure</title>
            <link>http://www.medworm.com/index.php?rid=1806164&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj05805439g558477%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;A high level of systemic oxidative stress exists in ALF, with depletion of antioxidant reserves. Further studies are needed
 to define the clinical correlation of the large pro-oxidant burden.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9098-6Authors
		Vikram Bhatia, All India Institute of Medical Sciences Department of Gastroenterology and Human Nutrition New Delhi 110029 IndiaPayal Bhardwaj, All India Institute of Medical Sciences Department of Gastroenterology and Human Nutrition New Delhi 110029 IndiaJessina Elikkottil, All India Institute of Medical Sciences Department of Gastroenterology and Human Nutrition New Delhi 110029 IndiaJyoti Batra, All India Institute of Medical Sciences Department of Gastroenterology and Human Nu...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1806164</comments>
            <pubDate>Tue, 16 Sep 2008 09:25:46 +0100</pubDate>
            <guid isPermaLink="false">1806164</guid>        </item>
        <item>
            <title>Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan®) before curative resection of hepatocellular carcinoma: a pilot study</title>
            <link>http://www.medworm.com/index.php?rid=1782542&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn7hu72717603u110%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;LSM is potentially useful to predict the development of postoperative hepatic insufficiency in patients with hepatocellular
 carcinoma undergoing curative liver resection surgery.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9091-0Authors
		Seung Up Kim, Yonsei University College of Medicine Department of Internal Medicine 250 Seongsanno, Seodaemun-gu Seoul 120–752 Republic of KoreaSang Hoon Ahn, Yonsei University College of Medicine Department of Internal Medicine 250 Seongsanno, Seodaemun-gu Seoul 120–752 Republic of KoreaJun Yong Park, Yonsei University College of Medicine Department of Internal Medicine 250 Seongsanno, Seodaemun-gu Seoul 120–752 Republic of KoreaDo Young Kim, Yonsei University College of Medicine Depart...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1782542</comments>
            <pubDate>Tue, 09 Sep 2008 00:35:13 +0100</pubDate>
            <guid isPermaLink="false">1782542</guid>        </item>
        <item>
            <title>Pretreatment and on-treatment predictors of viral breakthrough in lamivudine therapy for chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=1775500&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw8665n1631l0636p%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Persistence of HBeAg at 1&amp;nbsp;year and HBV DNA nonresponder at 6&amp;nbsp;months are good predictors of development of VBT.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9095-9Authors
		Shahinul Alam, Bangabandhu Sheikh Mujib Medical University Department of Hepatology Shahbag Dhaka BangladeshGolam Azam, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders Department of Immunology Shahbag Dhaka BangladeshGolam Mustafa, Bangabandhu Sheikh Mujib Medical University Department of Hepatology Shahbag Dhaka BangladeshNooruddin Ahmad, Bangabandhu Sheikh Mujib Medical University Department of Hepatology Shahbag Dhaka BangladeshBelalul Islam, Bangabandhu Sheikh Mujib Medical University Department of...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1775500</comments>
            <pubDate>Fri, 05 Sep 2008 15:13:38 +0100</pubDate>
            <guid isPermaLink="false">1775500</guid>        </item>
        <item>
            <title>Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver</title>
            <link>http://www.medworm.com/index.php?rid=1775501&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm7026r27xu6022p8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The Asian Pacific Association for the Study of the Liver (APASL) set up a Working Party on Portal Hypertension in 2002, with
 a mandate to develop consensus guidelines on various clinical aspects of portal hypertension relevant to disease patterns
 and clinical practice in the Asia-Pacific region. Variceal bleeding is a consequence of portal hypertension, which, in turn,
 is the major complication of liver cirrhosis. Primary prophylaxis to prevent the first bleed from varices is one of the most
 important strategies for reducing the mortality in cirrhotic patients. Experts predominantly from the Asia-Pacific region
 were requested to identify the different aspects of primary prophylaxis and develop the consensus guidelines. The APASL Working
 Party on Portal Hypertensio...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1775501</comments>
            <pubDate>Fri, 05 Sep 2008 15:13:37 +0100</pubDate>
            <guid isPermaLink="false">1775501</guid>        </item>
        <item>
            <title>Pharmacological effects are model specific in animal models of portal hypertension</title>
            <link>http://www.medworm.com/index.php?rid=1763843&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fuj7qt2440j316206%2F</link>
            <description>Content Type Journal ArticleCategory EditorialDOI 10.1007/s12072-008-9097-7Authors
		Flemming Bendtsen, University of Copenhagen Department of Medical Gastroenterology 439, Hvidovre Hospital and Faculty of Health Science Hvidovre 2650 DenmarkSøren Møller, University of Copenhagen Department of Clinical Physiology and Nuclear Medicine 239, Hvidovre Hospital and Faculty of Health Science Hvidovre 2650 Denmark
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1763843</comments>
            <pubDate>Wed, 03 Sep 2008 08:19:08 +0100</pubDate>
            <guid isPermaLink="false">1763843</guid>        </item>
        <item>
            <title>Biliary complications in liver transplantation</title>
            <link>http://www.medworm.com/index.php?rid=1763844&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkq2m1114786453nx%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Biliary complications of living donor liver transplantation remain common. The complications of biliary leakage and stricture
 result in substantial recipient morbidity. A major focus of liver transplantation research is the prevention and reduction
 of these complications through identification of the multiple factors that are conducive to them. Such factors include the
 donor bile duct anatomy and quality, and the techniques of donor hepatectomy, recipient hepatectomy, and ductal reconstruction.
 A low threshold for re-exploration for possible bile leakage prevents development of uncontrolled sepsis. Return of good graft
 function can usually be expected after successful early endoscopic treatment. Contingent measures of percutaneous transhepatic
 dilatation and stent...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1763844</comments>
            <pubDate>Wed, 03 Sep 2008 08:19:05 +0100</pubDate>
            <guid isPermaLink="false">1763844</guid>        </item>
        <item>
            <title>Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy</title>
            <link>http://www.medworm.com/index.php?rid=1763845&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb016t1578611hq85%2F</link>
            <description>This article reviews the development of a human recombinant single-chain
 antibody (scAb) that binds to the surface of myofibroblasts. This antibody binds specifically to myofibroblasts in fibrotic
 mouse livers. When conjugated with a compound that stimulates myofibroblast apoptosis, the antibody directs the specific apoptosis
 of myofibroblasts with greater specificity and efficacy than the free compound. The antibody also reduces the adverse effect
 of liver macrophage apoptosis and—in contrast to the free compound—reversed fibrosis in the sustained injury model used. These
 data suggest that specifically stimulating the apoptosis of liver myofibroblasts using a targeting antibody has potential
 in the treatment of liver fibrosis.
 
	Content Type Journal ArticleCategory Review Artic...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1763845</comments>
            <pubDate>Wed, 03 Sep 2008 08:19:02 +0100</pubDate>
            <guid isPermaLink="false">1763845</guid>        </item>
        <item>
            <title>Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study</title>
            <link>http://www.medworm.com/index.php?rid=1750013&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk545251256571161%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Through 96&amp;nbsp;weeks of treatment, entecavir resulted in continued clinical benefit in nucleoside-naïve Chinese patients with
 CHB, with a safety profile comparable with lamivudine.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9088-8Authors
		Guangbi Yao, Shanghai Jing An Qu Central Hospital No. 259 Xikang Road Shanghai 200040 ChinaChengWei Chen, Shanghai Liver Disease Research Center of the Nanjing Military Area, The 85th Hospital of PLA Shanghai ChinaWeiLun Lu, Zhongshan University No. 3 Hospital Guangzhou ChinaHong Ren, Chongqing Medical University 2nd Hospital Chongqing ChinaDeMing Tan, Xiang Ya Hospital, Central South University Department of Infectious Diseases Changsha ChinaYuMing Wang, 3rd Military Medical University So...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1750013</comments>
            <pubDate>Sat, 30 Aug 2008 09:22:08 +0100</pubDate>
            <guid isPermaLink="false">1750013</guid>        </item>
        <item>
            <title>A case of primary small cell carcinoma of the liver that was treated with chemotherapy</title>
            <link>http://www.medworm.com/index.php?rid=1729333&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcg14l02411053473%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Primary small cell carcinoma (SSC) of the liver is very rare in Japan and only ten cases have been reported worldwide. We
 report herein the case of a 77-year-old man with primary SCC of the liver. He had a tumor over 10&amp;nbsp;cm in diameter which was
 localized in the right lobe of the liver and had invaded the right diaphragm. In laboratory tests, high serum levels of lactate
 dehydrase and neuron-specific enolase were observed. A biopsy specimen showed that the tumor cells were similar in cytology
 to a pulmonary SCC. The patient was first treated with carboplatin and etoposide according to the therapy protocol for pulmonary
 SCC and then with a regimen using etoposid and cisplatinum, resulting in an unfavorable outcome. We discuss the clinical course
 and therapy of ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1729333</comments>
            <pubDate>Fri, 22 Aug 2008 09:50:04 +0100</pubDate>
            <guid isPermaLink="false">1729333</guid>        </item>
        <item>
            <title>The First China-Indonesia Joint International Symposium on Hepatobiliary Medicine and Surgery</title>
            <link>http://www.medworm.com/index.php?rid=1713851&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp4xg208854071335%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-007-9037-y

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1713851</comments>
            <pubDate>Sun, 17 Aug 2008 13:40:51 +0100</pubDate>
            <guid isPermaLink="false">1713851</guid>        </item>
        <item>
            <title>Errata</title>
            <link>http://www.medworm.com/index.php?rid=1704645&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhj73733n2406h728%2F</link>
            <description>Content Type Journal ArticleCategory ErratumDOI 10.1007/s12072-008-9089-7Authors
		Masao Omata, The University of Tokyo Department of Gastroenterology, Graduate School of Medicine 7-3-1 Hongo, Bunkyo-ku Tokyo 113-8655 JapanShiv Kumar Sarin, University of Delhi G. B. Pant Hospital #201, Academic Block New Delhi 110 002 India
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1704645</comments>
            <pubDate>Tue, 12 Aug 2008 07:32:48 +0100</pubDate>
            <guid isPermaLink="false">1704645</guid>        </item>
        <item>
            <title>Spontaneous bacterial peritonitis from 
 Salmonella
 : an unusual bacterium with unusual presentation</title>
            <link>http://www.medworm.com/index.php?rid=1657129&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4702n97rl61p0m61%2F</link>
            <description>We report a case of Salmonella SBP occurring in a patient with decompensated cryptogenic cirrhosis with concurrent low-grade non-Hodgkin lymphoma and prior
 treatment with rituximab. Physicians should be aware of the atypical presentation, especially in cirrhotic patients who are
 immunosuppressed.
 
	Content Type Journal ArticleCategory Case ReportDOI 10.1007/s12072-008-9087-9Authors
		Harshal Rajekar, Asian Center for Liver Diseases and Transplantation Gleneagles Hospital Annexe Block #02-37, 6A Napier Road Singapore Singapore 258500Chun-Tao Wai, Asian Center for Liver Diseases and Transplantation Gleneagles Hospital Annexe Block #02-37, 6A Napier Road Singapore Singapore 258500Kang-Hoe Lee, Asian Center for Liver Diseases and Transplantation Gleneagles Hospital Annexe Block #02-37, 6A N...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1657129</comments>
            <pubDate>Fri, 25 Jul 2008 06:55:43 +0100</pubDate>
            <guid isPermaLink="false">1657129</guid>        </item>
        <item>
            <title>The Roadmap concept: using early on-treatment virologic responses to optimize long-term outcomes for patients with chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=1657133&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3221470443000114%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Several large observational, longitudinal studies of the natural history of chronic hepatitis B (CHB) have demonstrated that
 high levels of hepatitis B virus (HBV) replication are associated with long-term risk of cirrhosis, decompensation, hepatocellular
 carcinoma, and liver-related mortality. The corollary is also true—profound and sustained suppression either spontaneously
 or during antiviral therapy will prevent disease progression and complications. Multiple analyses of various baseline factors
 and on-treatment responses have identified the absolute HBV DNA level after 24&amp;nbsp;weeks of therapy as the best predictor of long-term
 efficacy. Lower 24-week serum HBV DNA levels after lamivudine, telbivudine, or entecavir are associated with higher rates
 of mainta...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1657133</comments>
            <pubDate>Fri, 25 Jul 2008 06:55:42 +0100</pubDate>
            <guid isPermaLink="false">1657133</guid>        </item>
        <item>
            <title>Effects of 
 S
 -adenosylmethionine on liver methionine metabolism and steatosis with ethanol-induced liver injury in rats</title>
            <link>http://www.medworm.com/index.php?rid=1657132&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb01g7j23934192l7%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;SAM prevents alcohol-induced liver injury in rats by reducing liver lipid peroxidation, anti-inflammation, and antihyperplasia.
 In addition, it does not affect the plasma tHcy levels.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9082-1Authors
		Zuojiong Gong, State Key Laboratory of Virology, Renmin Hospital of Wuhan University Department of Infectious Diseases Wuhan 430060 ChinaShaonan Yan, State Key Laboratory of Virology, Renmin Hospital of Wuhan University Department of Infectious Diseases Wuhan 430060 ChinaPing Zhang, State Key Laboratory of Virology, Renmin Hospital of Wuhan University Department of Infectious Diseases Wuhan 430060 ChinaYanqing Huang, State Key Laboratory of Virology, Renmin Hospital of Wuhan University Dep...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1657132</comments>
            <pubDate>Fri, 25 Jul 2008 06:55:42 +0100</pubDate>
            <guid isPermaLink="false">1657132</guid>        </item>
        <item>
            <title>Successful treatment with lamivudine may correlate with reduction of serum ferritin levels in the patients with chronic hepatitis and liver cirrhosis type B</title>
            <link>http://www.medworm.com/index.php?rid=1657131&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu805923583n06785%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Successful treatment with LAM may reduce serum ferritin levels and improve hepatic siderosis in a subset of patients with
 chronic HBV infection.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9084-zAuthors
		Shogo Ohkoshi, Graduate School of Medical and Dental Sciences of Niigata University Division of Gastroenterology and Hepatology 1-754, Asahimachi-Dori Niigata-city 951-8122 JapanAkira Yoshimura, Graduate School of Medical and Dental Sciences of Niigata University Division of Gastroenterology and Hepatology 1-754, Asahimachi-Dori Niigata-city 951-8122 JapanSatoshi Yamamoto, Graduate School of Medical and Dental Sciences of Niigata University Division of Radiology 1-754, Asahimachi-Dori Niigata-city 951-8122 JapanMasahiko Yano, G...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1657131</comments>
            <pubDate>Fri, 25 Jul 2008 06:55:42 +0100</pubDate>
            <guid isPermaLink="false">1657131</guid>        </item>
        <item>
            <title>A prospective study of antituberculous drug-induced hepatotoxicity in an area endemic for liver diseases</title>
            <link>http://www.medworm.com/index.php?rid=1657130&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk60xt46142066623%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp; Anti-TB-DIH is not uncommon, needs early recognition and treatment, and is more in patients with pre-existing liver disease
 and low BMI.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9085-yAuthors
		Hoda A. Makhlouf, Assiut University Department of Chest Diseases, Faculty of Medicine Assiut 71111 EgyptAhmed Helmy, Assiut University Department of Tropical Medicine &amp; Gastroenterology, Faculty of Medicine Assiut 71111 EgyptEhab Fawzy, Assiut University Department of Tropical Medicine &amp; Gastroenterology, Faculty of Medicine Assiut 71111 EgyptMadiha El-Attar, Assiut University Department of Tropical Medicine &amp; Gastroenterology, Faculty of Medicine Assiut 71111 EgyptHebat Alla G. Rashed, Assiut University Department of Clinical Patholo...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1657130</comments>
            <pubDate>Fri, 25 Jul 2008 06:55:42 +0100</pubDate>
            <guid isPermaLink="false">1657130</guid>        </item>
        <item>
            <title>Demographics of a large cohort of urban chronic hepatitis C patients</title>
            <link>http://www.medworm.com/index.php?rid=1657134&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft1n6013111002133%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In this large cohort of CHC patients from a single institution, AA were older at presentation, had a higher prevalence of
 genotype 1, but significantly lower ALT levels than NHW.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9086-xAuthors
		Firdous A. Siddiqui, Wayne State University School of Medicine Division of Gastroenterology Detroit MI USAMurray N. Ehrinpreis, Wayne State University School of Medicine Division of Gastroenterology Detroit MI USAJames Janisse, Wayne State University School of Medicine Division of Family Medicine and Public Health Sciences Detroit MI USARavi Dhar, Wayne State University School of Medicine Division of Gastroenterology Detroit MI USAElizabeth May, Wayne State University School of Medicine Divisi...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1657134</comments>
            <pubDate>Fri, 25 Jul 2008 06:55:41 +0100</pubDate>
            <guid isPermaLink="false">1657134</guid>        </item>
        <item>
            <title>Updates in the pathogenesis, diagnosis and management of ectopic varices</title>
            <link>http://www.medworm.com/index.php?rid=1488091&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5tl5803h53lw7311%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ectopic varices (EcV) comprise large portosystemic venous collaterals located anywhere other than the gastro-oesophageal region.
 No large series or randomized-controlled trials address this subject, and therefore its management is based on available expertise
 and facilities, and may require a multidisciplinary team approach. EcV are common findings during endoscopy in portal hypertensive
 patients and their bleeding accounts for only 1–5% of all variceal bleeding. EcV develop secondary to portal hypertension
 (PHT), surgical procedures, anomalies in venous outflow, or abdominal vascular thrombosis and may be familial in origin. Bleeding
 EcV may present with anaemia, shock, haematemesis, melaena or haematochezia and should be considered in patients with PHT
 and gas...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1488091</comments>
            <pubDate>Sat, 31 May 2008 07:06:06 +0100</pubDate>
            <guid isPermaLink="false">1488091</guid>        </item>
        <item>
            <title>Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=1481805&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft75n62n34082t831%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Although the efficacy of lamivudine is limited because of breakthrough hepatitis, adefovir was used as a salvage treatment
 of patients with lamivudine-resistant chronic hepatitis B. In addition, lamivudine was used for the treatment of Japanese
 patients with chronic hepatitis B with or without lamivudine resistance, and was found to be useful regarding the long-term
 virologic and biochemical responses.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9081-2Authors
		Satoshi Shakado, Fukuoka University School of Medicine The Department of Gastroenterology and Hepatology 7-45-1 Nanakuma, Jonan-ku Fukuoka 814-0180 JapanHiroshi Watanabe, Fukuoka University School of Medicine The Department of Gastroenterology and Hepatology 7-45-1 Nan...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1481805</comments>
            <pubDate>Fri, 30 May 2008 06:00:25 +0100</pubDate>
            <guid isPermaLink="false">1481805</guid>        </item>
        <item>
            <title>Abstract</title>
            <link>http://www.medworm.com/index.php?rid=1450199&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F633706w4251m092w%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-008-9079-9

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1450199</comments>
            <pubDate>Fri, 16 May 2008 05:53:49 +0100</pubDate>
            <guid isPermaLink="false">1450199</guid>        </item>
        <item>
            <title>Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update</title>
            <link>http://www.medworm.com/index.php?rid=1436757&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdu475u12q655175j%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Large amounts of new data on the natural history and treatment of chronic hepatitis B virus (HBV) infection have become available
 since 2005. These include long-term follow-up studies in large community-based cohorts or asymptomatic subjects with chronic
 HBV infection, further studies on the role of HBV genotype/naturally occurring HBV mutations, treatment of drug resistance
 and new therapies. In addition, Pegylated interferon α2a, entecavir and telbivudine have been approved globally. To update
 HBV management guidelines, relevant new data were reviewed and assessed by experts from the region, and the significance of
 the reported findings were discussed and debated. The earlier “Asian-Pacific consensus statement on the management of chronic
 hepatitis B” was r...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1436757</comments>
            <pubDate>Sat, 10 May 2008 09:06:17 +0100</pubDate>
            <guid isPermaLink="false">1436757</guid>        </item>
        <item>
            <title>The effect of iron depletion on chronic hepatitis C virus infection</title>
            <link>http://www.medworm.com/index.php?rid=1432332&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv822q28295h16632%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Increasing evidence exists that iron overload, a common finding in chronic hepatitis C virus (HCV) infection, plays an important
 role in the pathophysiology of this disease. The mechanisms by which iron excess induces liver damage along with the benefit
 of iron depletion via phlebotomy on biochemical and histological outcomes in patients with chronic HCV infection have been
 discussed in this review. Finally, we focus on the effect of iron reduction on the rate of response to interferon antiviral
 therapy.
 
	Content Type Journal ArticleCategory Review ArticleDOI 10.1007/s12072-008-9076-zAuthors
		Massimo Franchini, Piazzale Ludovico Scuro Servizio di Immunoematologia e Trasfusione, Centro Emofilia, Azienda Ospedaliera di Verona, Ospedale Policlinico Verona 37134 Ital...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1432332</comments>
            <pubDate>Thu, 08 May 2008 05:51:48 +0100</pubDate>
            <guid isPermaLink="false">1432332</guid>        </item>
        <item>
            <title>Acute fatal presentation of ornithine transcarbamylase deficiency in a previously healthy male</title>
            <link>http://www.medworm.com/index.php?rid=1432333&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn8tw30776j0t7080%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ornithine transcarbamylase (OTC) deficiency is an X-linked urea cycle defect. While hemizygous males typically present with
 hyperammonemic coma in infancy, reports of rare late-onset presentations exist, with poor outcomes in males up to 58&amp;nbsp;years
 old. Relatives with mutations identical to affected patients often remain asymptomatic, and it is likely that environmental
 and genetic factors influence disease penetrance and expression. Here, we present our investigation of a patient with late-onset
 presentation, and we emphasize the potential role of environmental and genetic factors on disease expression. The patient
 was a previously healthy 62-year-old man who developed mental slowing, refractory seizures, and coma over an 8-day period.
 Interestingly, the patie...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1432333</comments>
            <pubDate>Wed, 07 May 2008 14:28:57 +0100</pubDate>
            <guid isPermaLink="false">1432333</guid>        </item>
        <item>
            <title>The economics of treating chronic hepatitis B in Asia</title>
            <link>http://www.medworm.com/index.php?rid=1417831&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl302714255605664%2F</link>
            <description>In conclusion, cost-effectiveness
 analysis is an important tool for health care administrators, clinicians, and patients to decide on the optimal therapy for
 chronic hepatitis B, but the methodology permits considerable leeway for interpretation of results, thus a combination of
 cost-effective indices may be needed to paint a more complete picture.
 
	Content Type Journal ArticleCategory Review ArticleDOI 10.1007/s12072-008-9049-2Authors
		Yock Young Dan, National University Hospital Department of Gastroenterology and Hepatology 5 Lower Kent Ridge Road Singapore 119074 SingaporeMyat Oo Aung, Centre for Molecular Medicine, Agency for Science, Technology and Research Singapore SingaporeSeng Gee Lim, National University Hospital Department of Gastroenterology and Hepatology 5 Lower Kent Ri...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1417831</comments>
            <pubDate>Thu, 01 May 2008 05:58:41 +0100</pubDate>
            <guid isPermaLink="false">1417831</guid>        </item>
        <item>
            <title>Hepatocellular adenoma: what is new in 2008</title>
            <link>http://www.medworm.com/index.php?rid=1417832&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc5327k2345721643%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Patients (85%) with hepatocellular adenoma (HCA) are women taking oral contraceptives. They can be divided into four subgroups
 according to their genotype/phenotype features. (1) Hepatocyte nuclear factor 1α (HNF1α) biallelic somatic mutations are observed
 in 35% of the HCA cases. It occurs in almost all cases in women. HNF1α-mutated HCA are most of the time, highly steatotic,
 with a lack of expression of liver fatty acid binding protein (LFABP) in immunohistochemistry analyses. Adenomatosis is frequently
 detected in this context. An HNF1α germline mutation is observed in less than 5% of HCA cases and can be associated with MODY
 3 diabetes. (2) An activating β-catenin mutation was found in 10% of HCA. These β-catenin activated HCAs are observed in men
 and wo...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1417832</comments>
            <pubDate>Thu, 01 May 2008 05:58:40 +0100</pubDate>
            <guid isPermaLink="false">1417832</guid>        </item>
        <item>
            <title>Introduction</title>
            <link>http://www.medworm.com/index.php?rid=1397588&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbm605k164q039142%2F</link>
            <description>Content Type Journal ArticleDOI 10.1007/s12072-008-9069-yAuthors
		Stephen Locarnini, Victorian Infectious Diseases Reference Laboratory Research and Molecular Development 10 Wreckyn Street North Melbourne 3051 VIC Australia
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533
	
		Journal Volume Volume 2
	
		Journal Issue Volume 2, Supplement 1 / May, 2008 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1397588</comments>
            <pubDate>Wed, 23 Apr 2008 16:18:50 +0100</pubDate>
            <guid isPermaLink="false">1397588</guid>        </item>
        <item>
            <title>Nitric oxide levels in chronic liver disease patients with and without oesophageal varices</title>
            <link>http://www.medworm.com/index.php?rid=1395074&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0764572162u4007g%2F</link>
            <description>Conclusion Serum nitrate level can be used as a non-invasive predictor for progression of chronic liver disease as well as for the presence
 of oesophageal varices.
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9077-yAuthors
		Assem M. El-Sherif, Al-Azhar Faculty of Medicine Internal Medicine Department Nasr City Cairo EgyptMohamed A. Abou-Shady, Al-Azhar Faculty of Medicine Internal Medicine Department Nasr City Cairo EgyptAshraf M. Al-Bahrawy, Al-Azhar Faculty of Medicine Internal Medicine Department Nasr City Cairo EgyptReda M. Bakr, Al-Azhar Faculty of Medicine Internal Medicine Department Nasr City Cairo EgyptAbdel-Moneim M. Hosny, Al-Azhar Faculty of Medicine Clinical Pathology Department Nasr City Cairo Egypt
	

	
		Journal Hepatology InternationalOn...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1395074</comments>
            <pubDate>Tue, 22 Apr 2008 14:22:21 +0100</pubDate>
            <guid isPermaLink="false">1395074</guid>        </item>
        <item>
            <title>Summary of the 2nd Asia Pacific Association for the Study of the Liver Diseases (APASL) Autumn Single Topic Conference 2007 The Innovation in Chronic Hepatitis B Treatment</title>
            <link>http://www.medworm.com/index.php?rid=1377922&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm10037r727m62673%2F</link>
            <description>Content Type Journal ArticleCategory Others (Announcements, etc.)DOI 10.1007/s12072-008-9073-2Authors
		Chutima Pramoolsinsap, 32/23 Sino_-Thai Tower 14th fl Bangkok Thailand
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1377922</comments>
            <pubDate>Tue, 15 Apr 2008 08:04:23 +0100</pubDate>
            <guid isPermaLink="false">1377922</guid>        </item>
        <item>
            <title>Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension</title>
            <link>http://www.medworm.com/index.php?rid=1371895&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F10142wm43247x236%2F</link>
            <description>Conclusions This study showed that propranolol has a significant hemodynamic effect only in the CCl4 model and suggested a model-dependent effect of propranolol.
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9070-5Authors
		Lionel Fizanne, Université d’Angers Laboratoire HIFIH, UPRES EA 3859, UFR de Médecine Angers FranceNicolas Régenet, Université d’Angers Laboratoire HIFIH, UPRES EA 3859, UFR de Médecine Angers FranceJianhua Wang, Université d’Angers Laboratoire HIFIH, UPRES EA 3859, UFR de Médecine Angers FranceFrédéric Oberti, Université d’Angers Laboratoire HIFIH, UPRES EA 3859, UFR de Médecine Angers FranceFrédéric Moal, Université d’Angers Laboratoire HIFIH, UPRES EA 3859, UFR de Médecine Angers FranceJerôme Roux, Universit...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1371895</comments>
            <pubDate>Sat, 12 Apr 2008 09:32:22 +0100</pubDate>
            <guid isPermaLink="false">1371895</guid>        </item>
        <item>
            <title>Chronic hepatitis B virus (HBV) infection in pregnancy</title>
            <link>http://www.medworm.com/index.php?rid=1371894&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F986382460874v770%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Pregnancy is associated with serum ALT elevation and HBeAg loss in patients with chronic HBV infection in the peri-partum
 period.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9063-4Authors
		Hui-Hui Tan, Singapore General Hospital Department of Gastroenterology &amp; Hepatology 1 Hospital Drive, Outram Road Singapore Singapore 169608Hock-Foong Lui, Singapore General Hospital Department of Gastroenterology &amp; Hepatology 1 Hospital Drive, Outram Road Singapore Singapore 169608Wan-Cheng Chow, Singapore General Hospital Department of Gastroenterology &amp; Hepatology 1 Hospital Drive, Outram Road Singapore Singapore 169608
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1371894</comments>
            <pubDate>Sat, 12 Apr 2008 09:32:22 +0100</pubDate>
            <guid isPermaLink="false">1371894</guid>        </item>
        <item>
            <title>Hepatitis E vaccine</title>
            <link>http://www.medworm.com/index.php?rid=1366592&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft26160831v588518%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hepatitis E is an emerging disease in resource-poor regions of the world. It is estimated that about 2&amp;nbsp;billion people live
 in areas endemic for this disease. The inability to reproducibly culture hepatitis E virus makes it impossible to develop
 traditional live or inactivated vaccines. However, significant progress has been made in developing and testing recombinant
 subunit vaccines based on the viral capsid protein. This review summarizes these efforts.
 
	Content Type Journal ArticleCategory Review ArticleDOI 10.1007/s12072-008-9071-4Authors
		Rakesh Aggarwal, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS) Department of Gastroenterology Rae Bareilly Road Lucknow 226 014 IndiaShahid Jameel, International Centre for Genetic Engineering and Bi...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1366592</comments>
            <pubDate>Thu, 10 Apr 2008 06:51:32 +0100</pubDate>
            <guid isPermaLink="false">1366592</guid>        </item>
        <item>
            <title>Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=1366591&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb66l438060nutn02%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Concurrent hepatitis C virus (HCV), hepatitis delta virus (HDV), or human immunodeficiency virus (HIV) infection with chronic
 hepatitis B virus (HBV) appears to increase the risk of progressive liver disease including liver cirrhosis and hepatocellular
 carcinoma. There is a 10% prevalence of HCV infection in chronic HBV or HDV infection. Serological evidence of previous exposure
 to HBV is found in more than 80% of HIV-positive patients in the high risk group. Notably, the most recently acquired virus
 tends to suppress the pre-existing virus. In chronic HBV infection acquired perinatally or in early childhood, usually HCV
 is dominant and may suppress or even displace HBV and HDV. Less frequently, HBV or HDV suppresses HCV. It is generally agreed
 that the dominant v...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1366591</comments>
            <pubDate>Thu, 10 Apr 2008 06:51:32 +0100</pubDate>
            <guid isPermaLink="false">1366591</guid>        </item>
        <item>
            <title>Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis</title>
            <link>http://www.medworm.com/index.php?rid=1364884&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9j73p7w448582175%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;TGF-α mRNA is an early predictor of FH outcome and a sensitive biomarker of lower regenerative liver capacity. This assay
 could help facilitate early therapy choice, such as liver transplantation.
 
 
 
	Content Type Journal ArticleCategory ORIGINAL ARTICLEDOI 10.1007/s12072-008-9053-6Authors
		Norimasa Miura, Tottori University Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine Nishicho 86 Yonago Tottori 683-8503 JapanHiroko Kabashima, Tottori University Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, Faculty of Medicine Nishicho 86 Yonago Tottori 683-8503 JapanMika Shimizu, Tottori University Division of Pharmacotherapeutics, Department of Pathophysiological a...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1364884</comments>
            <pubDate>Wed, 09 Apr 2008 05:59:24 +0100</pubDate>
            <guid isPermaLink="false">1364884</guid>        </item>
        <item>
            <title>Spontaneous rupture of metastatic α-fetoprotein-producing gastric cancer of the liver</title>
            <link>http://www.medworm.com/index.php?rid=1362367&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F201678xm50378154%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;An 80-year-old man was admitted to our hospital because of the rupture of the liver. Laboratory data showed iron-deficiency
 anemia, although there was no liver dysfunction. A computed tomography scan showed large liver tumor with intraperitoneal
 hemorrhage, and since a serum level of α-fetoprotein (AFP) was extremely high, we initially suspected a rupture of hepatocellular
 carcinoma (HCC). Transarterial embolization was performed to stop bleeding from the tumor, followed by an endoscopic examination
 that revealed advanced gastric cancer. Histological analysis revealed that both the gastric and the hepatic tumors were moderately
 to poorly differentiated adenocarcinoma, as well as that both tumors were immunohistochemically positive for AFP. Finally,
 we diagnosed A...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1362367</comments>
            <pubDate>Tue, 08 Apr 2008 06:59:13 +0100</pubDate>
            <guid isPermaLink="false">1362367</guid>        </item>
        <item>
            <title>Pentoxifylline: not just for alcoholic hepatitis anymore?</title>
            <link>http://www.medworm.com/index.php?rid=1362366&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Faj66k6520m787g05%2F</link>
            <description>Content Type Journal ArticleCategory EditorialDOI 10.1007/s12072-008-9057-2Authors
		Roman E. Perri, Vanderbilt University Medical Center Division of Gastroenterology and Hepatology 21st Avenue South and Garland Avenue Nashville TN 37232 USAVijay H. Shah, Mayo Clinic GI Research Unit and Fiterman Center for Digestive Disease Rochester MN USA
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1362366</comments>
            <pubDate>Tue, 08 Apr 2008 06:59:13 +0100</pubDate>
            <guid isPermaLink="false">1362366</guid>        </item>
        <item>
            <title>Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure</title>
            <link>http://www.medworm.com/index.php?rid=1336249&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdw1867842rv0hkq7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Antiviral resistance is now the single most important factor in treatment failure using nucleos(t)ide analogues (NA). Primary
 drug resistance mutations refer to amino acid change(s) that result in reduced susceptibility to an antiviral agent. Secondary
 compensatory mutations restore replication defects associated with primary drug resistance and may be associated with low
 level reduced susceptibility. Several evolutionary pathways of drug resistant HBV have been observed in patients treated with
 NAs. It is possible that the drug resistance mutations selected with one agent may affect the efficacy of other NAs. Several
 major HBV-evolutionary NA-resistance pathways (rtM204I/V, rtN236T and rtA181T/V) have now been characterised. The rtM204V/I
 pathway is responsible f...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1336249</comments>
            <pubDate>Fri, 28 Mar 2008 08:44:44 +0100</pubDate>
            <guid isPermaLink="false">1336249</guid>        </item>
        <item>
            <title>Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers</title>
            <link>http://www.medworm.com/index.php?rid=1331307&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk5l61w57v4808616%2F</link>
            <description>Conclusions TLR3 expression by biliary epithelial cells increased at sites of ductular reaction in diseased livers; further study will
 be necessary to characterize it’s in vivo physiological role.
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9055-4Authors
		Minoru Nakamura, National Hospital Organization (NHO) Nagasaki Medical Center Clinical Research Center Kubara 2-1001-1 Omura, Nagasaki 856-8562 JapanKenji Funami, Hokkaido University Graduate School of Medicine Department of Microbiology and Immunology Sapporo JapanAtsumasa Komori, National Hospital Organization (NHO) Nagasaki Medical Center Clinical Research Center Kubara 2-1001-1 Omura, Nagasaki 856-8562 JapanTerufumi Yokoyama, National Hospital Organization (NHO) Nagasaki Medical Center Clinical R...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1331307</comments>
            <pubDate>Wed, 26 Mar 2008 15:03:02 +0100</pubDate>
            <guid isPermaLink="false">1331307</guid>        </item>
        <item>
            <title>Prognostic analysis of pulmonary metastases from hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=1307621&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm22g67264u567341%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;It was very important to treat the intrahepatic tumor because its worsening was still the major cause of death. The progressive
 treatment for pulmonary metastases may also be advised for possible prolongation of survival.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9052-7Authors
		Shu-Min Zhang, Fudan University Department of Radiation Oncology, Zhongshan Hospital Shanghai ChinaZhao-Chong Zeng, Fudan University Department of Radiation Oncology, Zhongshan Hospital Shanghai ChinaZhao-You Tang, Fudan University Liver Cancer Institute, Zhongshan Hospital Shanghai ChinaJing Sun, Fudan University Department of Radiation Oncology, Zhongshan Hospital Shanghai ChinaJie-Min Cheng, Fudan University Department of Radiology, Zhongshan Hospit...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1307621</comments>
            <pubDate>Sat, 15 Mar 2008 09:15:56 +0100</pubDate>
            <guid isPermaLink="false">1307621</guid>        </item>
        <item>
            <title>Chronic HBV infection with persistently normal ALT b. not to treat</title>
            <link>http://www.medworm.com/index.php?rid=1287786&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq062546061pj6051%2F</link>
            <description>Content Type Journal ArticleCategory Others (Announcements, etc.)DOI 10.1007/s12072-008-9068-zAuthors
		Kwang-Hyub Han, Yonsei University College of Medicine, Liver Cirrhosis Clinical Research Center Department of Internal Medicine Seoul KoreaDo Young Kim, Yonsei University College of Medicine, Liver Cirrhosis Clinical Research Center Department of Internal Medicine Seoul Korea
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1287786</comments>
            <pubDate>Thu, 06 Mar 2008 16:46:02 +0100</pubDate>
            <guid isPermaLink="false">1287786</guid>        </item>
        <item>
            <title>Natural history and clinical management of chronic hepatitis B virus infection in children</title>
            <link>http://www.medworm.com/index.php?rid=1287787&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg364568363311730%2F</link>
            <description>This article reviews current knowledge
 regarding the natural history and treatment of chronic hepatitis B in children. Factors that affect the natural history of
 HBV infection in children are also reviewed.
 
	Content Type Journal ArticleCategory ORIGINAL ARTICLEDOI 10.1007/s12072-008-9050-9Authors
		Mei-Hwei Chang, National Taiwan University Hospital Division of Gastroenterology and Hepatology, Department of Pediatrics No. 7, Chung-Shan S. Road Taipei Taiwan
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1287787</comments>
            <pubDate>Thu, 06 Mar 2008 16:46:01 +0100</pubDate>
            <guid isPermaLink="false">1287787</guid>        </item>
        <item>
            <title>Current approaches for treating chronic hepatitis B: when to start, what to start with, and when to stop</title>
            <link>http://www.medworm.com/index.php?rid=1284716&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F01k4581303255628%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The natural course of hepatitis B virus (HBV) infection is variable, and chronic hepatitis B (CHB) disease exhibits itself
 through a spectrum of clinical manifestations. These factors contribute to the challenges faced when managing patients who
 live with HBV infection. Furthermore, conventional treatment options (e.g., interferon alfa-2a, lamivudine, and adefovir)
 are moderately effective and can be associated with problems, such as poor tolerability (interferon alfa-2a) and the development
 of drug resistance (lamivudine). Over the last 5&amp;nbsp;years, several antiviral agents including entecavir, peginterferon alfa-2a,
 and telbivudine which are more efficacious and have improved tolerability over previous drugs have become available. The availability
 of novel anti...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1284716</comments>
            <pubDate>Wed, 05 Mar 2008 07:52:20 +0100</pubDate>
            <guid isPermaLink="false">1284716</guid>        </item>
        <item>
            <title>Hepatitis B reactivation after chemotherapy: two decades of clinical research</title>
            <link>http://www.medworm.com/index.php?rid=1284717&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy761302354w65633%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hepatitis due to hepatitis B virus reactivation after cytotoxic or immunosuppressive therapy is a serious cause of liver-related
 morbidity and mortality. With the characterization of the underlying pathogenesis, much progress in the management of this
 important clinical problem has been made in the past 2 decades. By year 2008, it is mandatory to screen for hepatitis B surface
 antigen status before initiating intensive chemotherapy or immunosuppressive therapy. All those who are hepatitis B surface
 antigen positive should be started on preemptive nucleos(t)ide analogues. However, there remains important issues, such as
 the type and duration of nucleos(t)ide analogue therapy, which need to be understood. As not all hepatitis B surface antigen-positive
 patients will...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1284717</comments>
            <pubDate>Wed, 05 Mar 2008 07:52:18 +0100</pubDate>
            <guid isPermaLink="false">1284717</guid>        </item>
        <item>
            <title>Should chronic HBV infected patients with normal ALT treated: debate</title>
            <link>http://www.medworm.com/index.php?rid=1282191&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu86266272m5972u1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Alanine aminotransferase (ALT) levels have traditionally been used for treatment decisions in chronic hepatitis B virus (CHBV)
 infected patients. But recent data have raised doubts on this wisdom, as a significant proportion of CHBV infected patients
 with normal ALT have high HBVDNA levels and significant liver injury at presentation especially in areas of intermediate to
 high endemicity. A normal ALT value only identifies patients less likely to respond to current treatments, rather than patients
 who are not in need of the treatment. Patients with CHBV infection with normal ALT should be considered for treatment based
 on the HBV DNA levels and histological injury.
 
	Content Type Journal ArticleCategory Review articleDOI 10.1007/s12072-008-9065-2Authors
		Shiv Kum...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1282191</comments>
            <pubDate>Tue, 04 Mar 2008 08:48:35 +0100</pubDate>
            <guid isPermaLink="false">1282191</guid>        </item>
        <item>
            <title>Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues</title>
            <link>http://www.medworm.com/index.php?rid=1282192&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb055058016152188%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Forty years ago in 1967, Professor Blumberg discovered the Australian Antigen, later known as the hepatitis B surface antigen,
 and was awarded the Nobel Prize. This discovery enables the diagnosis of hepatitis B virus (HBV) infection and defines its
 epidemiology. Viral hepatitis B infection affects global health situation, and chronic hepatitis B (CHB) is particularly serious
 in the Asia-Pacific region. HBV vaccines created the first breakthrough in HBV prevention. Through universal HBV vaccination
 program for the newborns, promoted since the mid-1980s, the main route that perpetuates chronic infection from mother to child
 is curbed. Most children and young adults now have immunity against HBV infection. The next breakthrough comes with therapy
 for CHB. This preve...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1282192</comments>
            <pubDate>Tue, 04 Mar 2008 08:48:34 +0100</pubDate>
            <guid isPermaLink="false">1282192</guid>        </item>
        <item>
            <title>Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=1282193&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft5035115728x5324%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The primary aim of immunomodulator therapy is to help the natural human immune system to mount a defense against hepatitis
 B virus. IFN-α has been used for the treatment of HBeAg-positive and HBeAg-negative chronic hepatitis B for over two decades
 and has been shown to be effective in suppressing HBV replication and in inducing serological response leading to long-term
 clinical benefits. IFN-α has been used in patients with well-compensated cirrhosis with comparable or better response to that
 in non-cirrhotic patients. IFN-α therapy in patients with cirrhosis has a similar side effect profile as in those without
 cirrhosis. However, IFN-α is contraindicated in patients with overt or decompensated cirrhosis. Pegylated IFN-α has been shown
 to be effective in tre...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1282193</comments>
            <pubDate>Tue, 04 Mar 2008 08:48:33 +0100</pubDate>
            <guid isPermaLink="false">1282193</guid>        </item>
        <item>
            <title>Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)
 -
 resistant hepatitis B virus (HBV)</title>
            <link>http://www.medworm.com/index.php?rid=1269539&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy208846566273047%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our results suggest that for LAM-resistant HBV, TDF, alone or combined with LAM exerts greater viral reduction than ADV. However,
 no difference in HBeAg loss was observed. It appears that stronger HBV DNA reduction may not necessarily accelerate HBeAg
 loss.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9045-6Authors
		Hie-Won Hann, Thomas Jefferson University Hospital Liver Disease Prevention Center, Division of Gastroenterology and Hepatology, Department of Medicine Philadelphia PA 19107-5587 USAHee Bok Chae, Thomas Jefferson University Hospital Liver Disease Prevention Center, Division of Gastroenterology and Hepatology, Department of Medicine Philadelphia PA 19107-5587 USAStephen R. Dunn, Thomas Jefferson University Hospital ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1269539</comments>
            <pubDate>Thu, 28 Feb 2008 15:51:39 +0100</pubDate>
            <guid isPermaLink="false">1269539</guid>        </item>
        <item>
            <title>A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)</title>
            <link>http://www.medworm.com/index.php?rid=1269541&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ffl3j222463314028%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Three months of Pentoxifylline treatment in combination with diet and exercise results in significantly greater reduction
 in AST levels in patients with NASH as compared with controls.
 
 
 
	Content Type Journal ArticleCategory NASH (NAFLD), PHT, Hepatic Failure and OthersDOI 10.1007/s12072-008-9058-1Authors
		Yin-Mei Lee, National University Hospital Department of Gastroenterology/Hepatology 5 Lower Kent Ridge Road Singapore 119074 SingaporeDede S. Sutedja, National University Hospital Department of Gastroenterology/Hepatology 5 Lower Kent Ridge Road Singapore 119074 SingaporeChun-Tao Wai, Gleneagles Hospital Asia Center for Liver Disease and Transplantation 6A Napier Road Singapore 258500 SingaporeYock-Young Dan, National University Hospital Department of Gastroen...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1269541</comments>
            <pubDate>Thu, 28 Feb 2008 15:51:38 +0100</pubDate>
            <guid isPermaLink="false">1269541</guid>        </item>
        <item>
            <title>Nonalcoholic fatty liver disease in a district general hospital: clinical presentation and risk factors</title>
            <link>http://www.medworm.com/index.php?rid=1269540&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7u65117x2268w226%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;NAFLD is common in the DGH and should be considered in all patients with metabolic risk factors. A liver biopsy should be
 considered in those with low platelets, type II diabetes mellitus, and the metabolic syndrome.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9044-7Authors
		Wing-Kin Syn, Princess Royal Hospital Apley Castle, Telford Shropshire TF1 6TF UKPeter Nightingale, Wellcome Trust Clinical Research Facility Birmingham UKJeffrey M. Bateman, Princess Royal Hospital Apley Castle, Telford Shropshire TF1 6TF UK
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1269540</comments>
            <pubDate>Thu, 28 Feb 2008 15:51:38 +0100</pubDate>
            <guid isPermaLink="false">1269540</guid>        </item>
        <item>
            <title>Metabolic profiles in patients with chronic hepatitis C: a case–control study</title>
            <link>http://www.medworm.com/index.php?rid=1269542&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx781935x44r276n0%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Metabolic profiles of chronic hepatitis C patients are affected by age, gender, serum adiponectin, and ALT levels. Further
 longitudinal studies are needed to clarify the complex interplay between HCV infection and metabolic profiles.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9064-3Authors
		Ching-Sheng Hsu, Buddhist Tzu Chi General Hospital Division of Gastroenterology Taipei Branch Taipei Taiwan, ROCChun-Jen Liu, National Taiwan University College of Medicine and National Taiwan University Hospital Department of Internal Medicine Taipei Taiwan, ROCChen-Hua Liu, National Taiwan University College of Medicine and National Taiwan University Hospital Department of Internal Medicine Taipei Taiwan, ROCChi-Ling Chen, National Taiwa...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1269542</comments>
            <pubDate>Thu, 28 Feb 2008 15:51:37 +0100</pubDate>
            <guid isPermaLink="false">1269542</guid>        </item>
        <item>
            <title>Comparative redox status in alcoholic liver disease and nonalcoholic fatty liver disease</title>
            <link>http://www.medworm.com/index.php?rid=1265088&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnhm58q175m874270%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;ALD patients have a higher degree of redox imbalance as compared with NAFLD patients
 
 
 
	Content Type Journal ArticleCategory NASH (NAFLD), PHT, Hepatic Failure and OthersDOI 10.1007/s12072-008-9060-7Authors
		Payal Bhardwaj, All India Institute of Medical Sciences Department of Gastroenterology and Human Nutrition Unit New Delhi 110029 IndiaKaushal Madan, All India Institute of Medical Sciences Department of Gastroenterology and Human Nutrition Unit New Delhi 110029 IndiaSandeep Thareja, All India Institute of Medical Sciences Department of Gastroenterology and Human Nutrition Unit New Delhi 110029 IndiaYogendra Kumar Joshi, All India Institute of Medical Sciences Department of Gastroenterology and Human Nutrition Unit New Delhi 110029 IndiaAnoop Saraya, All Indi...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1265088</comments>
            <pubDate>Wed, 27 Feb 2008 15:42:41 +0100</pubDate>
            <guid isPermaLink="false">1265088</guid>        </item>
        <item>
            <title>New concepts in the immunopathogenesis of chronic hepatitis B: the importance of the innate immune response</title>
            <link>http://www.medworm.com/index.php?rid=1265087&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe14j30500j725107%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Acute and chronic infection with hepatitis B virus (HBV) is associated with an increased risk of developing liver disease
 including cirrhosis, decompensated liver disease, and hepatocellular carcinoma. The clinical presentation and natural history
 of HBV infection is mediated through complex interactions between the virus and the host immune response. HBV is not directly
 cytopathic to heptocytes; however, the interaction between the virus and the host immune response plays a central role in
 the pathogenesis of necroinflammation and liver fibrosis. Emerging data from immunopathogenesis studies in animal models and
 in vitro studies of liver biopsies from patients with chronic hepatitis B demonstrate a potentially important interaction
 between hepatitis B e antigen, ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1265087</comments>
            <pubDate>Wed, 27 Feb 2008 15:42:41 +0100</pubDate>
            <guid isPermaLink="false">1265087</guid>        </item>
        <item>
            <title>Advanced hepatic fibrosis and cirrhosis due to nonalcoholic fatty liver disease in Sri Lankan children: a preliminary report</title>
            <link>http://www.medworm.com/index.php?rid=1265086&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F623w6w9278148416%2F</link>
            <description>We report the characteristics of 5 children with advanced hepatic fibrosis and cirrhosis due to NAFLD. Four of them
 were obese, and all of them had high alanine transaminase levels and ultrasonographic evidence of fatty liver. None had diabetes
 mellitus or hyperlipidemia. The calculated HOMA-IR was more than two in all five cases. Liver biopsy showed stage III fibrosis
 in 2 patients and stage IV fibrosis (cirrhosis) in 3.
 
	Content Type Journal ArticleCategory NASH (NAFLD), PHT, Hepatic Failure and OthersDOI 10.1007/s12072-008-9062-5Authors
		S. Rajindrajith, University of Kelaniya Department of Paediatrics, Faculty of Medicine Thalagolla Road Ragama Sri LankaA. S. Dassanayake, University of Kelaniya Department of Pharmacology, Faculty of Medicine Thalagolla Road Ragama Sri LankaJ. Hew...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1265086</comments>
            <pubDate>Wed, 27 Feb 2008 15:42:41 +0100</pubDate>
            <guid isPermaLink="false">1265086</guid>        </item>
        <item>
            <title>Economic evaluation of a surveillance program of hepatocellular carcinoma (HCC) in India</title>
            <link>http://www.medworm.com/index.php?rid=1265085&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw415531823532038%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The cost of HCC surveillance program is exorbitant for India (gross national income per capita US$ 620) and possibly other
 low/middle income countries.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-008-9054-5Authors
		Shashi Bala Paul, All India Institute of Medical Sciences Department of Radio-diagnosis New Delhi 110029 IndiaVishnubhatla Sreenivas, All India Institute of Medical Sciences Department of Biostatistics New Delhi 110029 IndiaManpreet Singh Gulati, All India Institute of Medical Sciences Department of Radio-diagnosis New Delhi 110029 IndiaKaushal Madan, All India Institute of Medical Sciences Department of Gastroenterology New Delhi 110029 IndiaArun Kumar Gupta, All India Institute of Medical Sciences Department of Radio-d...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1265085</comments>
            <pubDate>Wed, 27 Feb 2008 15:42:39 +0100</pubDate>
            <guid isPermaLink="false">1265085</guid>        </item>
        <item>
            <title>New developments in HBV molecular diagnostics and quantitative serology</title>
            <link>http://www.medworm.com/index.php?rid=1231773&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw4001n4w77788103%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;New standardized assays for the quantification of hepatitis B virus (HBV) DNA have yielded insights into the association of
 HBV DNA levels with the relative risk of developing liver disease. Quantification of HBV DNA has also played a role in the
 management of chronic hepatitis B by allowing criteria to be established for determining patient eligibility for antiviral
 therapy, monitoring response, and identifying the development of resistance. In addition to serum HBV DNA levels, the HBV
 genotype may influence disease progression and response to therapy. However, many of the studies that have included genotype
 assessment do not compare across the range of genotypes, and current management guidelines do not incorporate genotype determination.
 More recently, quantita...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1231773</comments>
            <pubDate>Wed, 13 Feb 2008 16:09:31 +0100</pubDate>
            <guid isPermaLink="false">1231773</guid>        </item>
        <item>
            <title>Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B</title>
            <link>http://www.medworm.com/index.php?rid=1215204&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkl3344452m6w0805%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In conclusion, a finite course of peginterferon alfa-2a provides significant and sustained treatment benefit in Asian CHB
 patients, who have traditionally been regarded as difficult to treat.
 
 
 
	Content Type Journal ArticleCategory ORIGINAL ARTICLEDOI 10.1007/s12072-007-9022-5Authors
		Teerha Piratvisuth, Prince of Songkla University Department of Internal Medicine, NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital Hat Yai Songkla 90110 ThailandGeorge Lau, Queen Mary Hospital Department of Medicine Hong Kong ChinaYou-Chen Chao, Tri-Service General Hospital Division of Gastroenterology and Hepatology Taipei TaiwanRui Jin, Beijing You-An Hospital Digestive Department Beijing ChinaAnuchit Chutaputti, Pramongkutklao Hospital Section of Diges...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1215204</comments>
            <pubDate>Tue, 05 Feb 2008 15:46:25 +0100</pubDate>
            <guid isPermaLink="false">1215204</guid>        </item>
        <item>
            <title>Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=1191304&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy62672785768557p%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Our results showed that even a single heat treatment could induce further transformation of an HCC cell line. Our results
 suggest that an insufficient treatment of HCC by RFA that enables survival of some cells might induce further malignant transformation
 in&amp;nbsp;vivo.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-007-9040-3Authors
		Koichi Obara, St. Marianna University School of Medicine Division of Gastroenterology and Hepatology 2-16-1 Sugao, Miyamae-ku Kawasaki City Kanagawa 216-8511 JapanNobuyuki Matsumoto, St. Marianna University School of Medicine Division of Gastroenterology and Hepatology 2-16-1 Sugao, Miyamae-ku Kawasaki City Kanagawa 216-8511 JapanMasaru Okamoto, St. Marianna University School of Medicine Division of Gas...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1191304</comments>
            <pubDate>Tue, 29 Jan 2008 15:45:09 +0100</pubDate>
            <guid isPermaLink="false">1191304</guid>        </item>
        <item>
            <title>Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China</title>
            <link>http://www.medworm.com/index.php?rid=1155773&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa85816781168919j%2F</link>
            <description>Content Type Journal ArticleCategory ErratumDOI 10.1007/s12072-007-9043-0Authors
		Guangbi Yao, Shanghai Jing An Qu Central Hospital No. 259 Xikang Rd Shanghai 200040 ChinaChengwei Chen, Shanghai Liver Disease Center of Nangjing Military Command Shanghai ChinaWeilun Lu, No. 3 Hospital Affiliated to Sun Yat-Sen University Guangzhou ChinaHong Ren, No. 2 Hospital Affiliated to Chongqing Medical University Chongqing ChinaDeming Tan, Infectious Disease Department of Xiang Ya Hospital Changsha ChinaYuming Wang, Xinan Hospital Chongqing ChinaDaozheng Xu, Beijing Di Tan Hospital Beijing ChinaZhengrong Jiang, Shanghai Roche Pharmaceutical Company Shanghai ChinaJessica Liu, Pharmaceutical Research Institution Bristol-Myers Squibb Company Braine-l’Alleud BelgiumDong Xu, Bristol-Myers Squibb Compa...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1155773</comments>
            <pubDate>Mon, 14 Jan 2008 23:23:04 +0100</pubDate>
            <guid isPermaLink="false">1155773</guid>        </item>
        <item>
            <title>Blood cell, liver function, and response changes by PEG-interferon-α2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C</title>
            <link>http://www.medworm.com/index.php?rid=1146153&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd6l1225t38733451%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The study demonstrated no evidence that zinc ameliorates hematologic side effects, improves liver function, and enhances the
 response to the therapy in chronic hepatitis C receiving PEG-IFN-α2b plus RBV.
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-007-9029-yAuthors
		Ke Ih Kim, Kobe Asahi Hospital Department of Pharmacy 3-5-25, Bououji-cho, Nagata-ku Kobe Hyogo 653-0801 JapanSoo Ryang Kim, Kobe Asahi Hospital Department of Gastroenterology Kobe JapanNoriko Sasase, Kobe Asahi Hospital Department of Pharmacy 3-5-25, Bououji-cho, Nagata-ku Kobe Hyogo 653-0801 JapanYoko Akimoto, Kobe Asahi Hospital Department of Pharmacy 3-5-25, Bououji-cho, Nagata-ku Kobe Hyogo 653-0801 JapanMao Shikata, Kobe Asahi Hospital Department of Pharmacy 3-5-25, Bououji-cho, Nagata-...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1146153</comments>
            <pubDate>Fri, 11 Jan 2008 16:24:18 +0100</pubDate>
            <guid isPermaLink="false">1146153</guid>        </item>
        <item>
            <title>Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=1126077&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw147t5664061vv46%2F</link>
            <description>Conclusions Diagnostic accuracy of AFP in small HCC was substantially limited. Surveillance including other tumor markers with optimal
 cutoff value should be conducted to confirm the efficacy of the policy.
 
	Content Type Journal ArticleCategory ORIGINAL ARTICLEDOI 10.1007/s12072-007-9038-xAuthors
		Ryosuke Tateishi, University of Tokyo Department of Gastroenterology, Graduate School of Medicine 7-3-1 Hongo, Bunkyo-ku Tokyo 113-8655 JapanHaruhiko Yoshida, University of Tokyo Department of Gastroenterology, Graduate School of Medicine 7-3-1 Hongo, Bunkyo-ku Tokyo 113-8655 JapanYutaka Matsuyama, University of Tokyo Department of Biostatistics, Graduate School of Medicine 7-3-1 Hongo, Bunkyo-ku Tokyo 113-8655 JapanNorio Mine, University of Tokyo Department of Gastroenterology, Graduate Scho...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1126077</comments>
            <pubDate>Mon, 31 Dec 2007 20:29:51 +0100</pubDate>
            <guid isPermaLink="false">1126077</guid>        </item>
        <item>
            <title>Correction of copper metabolism is not sustained long term in Wilson’s disease mice post bone marrow transplantation</title>
            <link>http://www.medworm.com/index.php?rid=1121679&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj20003p47x477165%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;These results demonstrate that bone marrow transplants cannot maintain disease correction in a mouse model of mild hepatic
 damage, although initial copper metabolism correction was observed.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-007-9039-9Authors
		Nicole E. Buck, University of Melbourne Murdoch Childrens Research Institute, Royal Children’s Hospital, Department of Paediatrics Flemington Road Parkville VIC 3052 AustraliaDaphne M. Y. Cheah, University of Melbourne Murdoch Childrens Research Institute, Royal Children’s Hospital, Department of Paediatrics Flemington Road Parkville VIC 3052 AustraliaNgaire J. Elwood, University of Melbourne Childrens Cancer Centre, Murdoch Childrens Research Institute, Royal Children’s Hospi...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1121679</comments>
            <pubDate>Fri, 28 Dec 2007 16:16:46 +0100</pubDate>
            <guid isPermaLink="false">1121679</guid>        </item>
        <item>
            <title>Adeno-associated virus vector-mediated production of hepatocyte growth factor attenuates liver fibrosis in mice</title>
            <link>http://www.medworm.com/index.php?rid=1116110&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk7q575g165658771%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;A single injection of AAV vector containing HGF gene achieved long-term expression of HGF and resulted in resolution of mouse
 liver fibrosis. HGF gene therapy mediated by AAV is feasible for the treatment of liver fibrosis.
 
 
 
	Content Type Journal ArticleCategory ORIGINAL ARTICLEDOI 10.1007/s12072-007-9042-1Authors
		Kazuhiro Suzumura, Hyogo College of Medicine First Department of Surgery 1-1 Mukogawacho Nishinomiya Hyogo 663-8501 JapanTadamichi Hirano, Hyogo College of Medicine First Department of Surgery 1-1 Mukogawacho Nishinomiya Hyogo 663-8501 JapanGakuhei Son, Hyogo College of Medicine First Department of Surgery 1-1 Mukogawacho Nishinomiya Hyogo 663-8501 JapanYuji Iimuro, Hyogo College of Medicine First Department of Surgery 1-1 Mukogawacho Nishinomiya Hy...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1116110</comments>
            <pubDate>Mon, 24 Dec 2007 17:34:59 +0100</pubDate>
            <guid isPermaLink="false">1116110</guid>        </item>
        <item>
            <title>Small-cell carcinoma of the extrahepatic bile duct: a case report and review of the literature</title>
            <link>http://www.medworm.com/index.php?rid=1106140&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr10976pn7v864232%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A small-cell carcinoma of the extrahepatic bile duct in a 69-year-old woman is herein reported. A tumor measuring approximately
 3&amp;nbsp;cm in diameter was located at the confluence of the common bile duct, cystic duct, and common hepatic duct. Histopathologically,
 the tumor was small-cell neuroendocrine carcinoma without any gland formation or differentiation to squamous cell carcinoma.
 Tumor cells were immunoreactive for epithelial markers such as epithelial membrane antigen and cytokeratin and for the neuroendocrine
 markers such as neuron-specific enolase, chromogranin A, and synaptophysin. Although the carcinomas in more than half of the
 reported cases have been reported to be associated with well-to-moderately differentiated squamous or glandular components,
 se...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1106140</comments>
            <pubDate>Tue, 18 Dec 2007 15:49:29 +0100</pubDate>
            <guid isPermaLink="false">1106140</guid>        </item>
        <item>
            <title>Noninvasive predictors of large varices in patients hospitalized with gastroesophageal variceal hemorrhage</title>
            <link>http://www.medworm.com/index.php?rid=1100039&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj65192214306mq57%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Cirrhosis with HCC, clinical splenomegaly, hemodynamic instability, a previous history of GEVH, thrombocytopenia (i.e., platelet
 count &amp;lt;91,000), and splenic size ≥158&amp;nbsp;mm are independent noninvasive predictors of large varices in patients hospitalized
 with gastroesophageal variceal hemorrhage.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-007-9034-1Authors
		Faisal Wasim Ismail, Aga Khan University Hospital Section of Gastroenterology, Department of Medicine Karachi 74800 PakistanHasnain A. Shah, Aga Khan University Hospital Section of Gastroenterology, Department of Medicine Karachi 74800 PakistanSaeed Hamid, Aga Khan University Hospital Section of Gastroenterology, Department of Medicine Karachi 74800 PakistanZaigham Abbas...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1100039</comments>
            <pubDate>Sat, 15 Dec 2007 19:42:35 +0100</pubDate>
            <guid isPermaLink="false">1100039</guid>        </item>
        <item>
            <title>Gender-based outcomes differences in unresectable hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=1100038&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft0w986665m415264%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;The present study provides evidence that female gender provides a distinct survival advantage over males in unresectable HCC
 presenting with similar tumor characteristics, liver function, and coexisting liver disease.
 
 
 
	Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s12072-007-9041-2Authors
		Shama C. Buch, University of Pittsburgh Center for Clinical Pharmacology Philadelphia PA USAVenkateswarlu Kondragunta, Duke University Durham NC USARobert A. Branch, University of Pittsburgh Center for Clinical Pharmacology Philadelphia PA USABrian I. Carr, Thomas Jefferson University Liver Cancer Program, Kimmel Cancer Center Bluemle Building, Room 1002, 233 S.10th Street Philadelphia PA 19107 USA
	

	
		Journal Hepatology InternationalOnline ISSN 1936-05...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1100038</comments>
            <pubDate>Sat, 15 Dec 2007 19:42:35 +0100</pubDate>
            <guid isPermaLink="false">1100038</guid>        </item>
        <item>
            <title>Immune selection during chronic hepadnavirus infection</title>
            <link>http://www.medworm.com/index.php?rid=1097184&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp31v56884106l034%2F</link>
            <description>Abstract
 Purpose&amp;nbsp;&amp;nbsp;Late-stage outcomes of chronic hepatitis B virus (HBV) infection, including fibrosis, cirrhosis, and hepatocellular carcinoma
 (HCC) result from persistent liver injury mediated by HBV antigen specific cytotoxic T lymphocytes (CTLs). Two other outcomes
 that often accompany chronic infection, the emergence of mutant viruses, including HBe-antigen negative (HBeAg (−)) HBV, and
 a reduction over time in the fraction of hepatocytes productively infected with HBV, may also result from persistent immune
 attack by antiviral CTLs. To gain insights into how these latter changes take place, we employed computer simulations of the
 chronically infected liver.
 
 
 
 Methods&amp;nbsp;&amp;nbsp;Computational programs were used to model the emergence of both virus-free hepatocyt...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1097184</comments>
            <pubDate>Fri, 14 Dec 2007 15:57:47 +0100</pubDate>
            <guid isPermaLink="false">1097184</guid>        </item>
        <item>
            <title>Antiviral therapy in patients with chronic hepatitis B and hepatocellular carcinoma: post-thermal ablation. Better late than never?</title>
            <link>http://www.medworm.com/index.php?rid=1074884&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fwh24q95931434141%2F</link>
            <description>Content Type Journal ArticleCategory EditorialDOI 10.1007/s12072-007-9036-zAuthors
		Eugene R. Schiff, University of Miami Miller School of Medicine Center for Liver Diseases Miami FL USA
	

	
		Journal Hepatology InternationalOnline ISSN 1936-0541Print ISSN 1936-0533 (Source: Hepatology International)</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1074884</comments>
            <pubDate>Wed, 05 Dec 2007 16:37:19 +0100</pubDate>
            <guid isPermaLink="false">1074884</guid>        </item>
        <item>
            <title>Actinomycotic hepatic abscess</title>
            <link>http://www.medworm.com/index.php?rid=1062741&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj086328u57567746%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Actinomycotic hepatic abscess was diagnosed in a 46-year-old male driver from Ukraine presenting with the symptoms of malaise,
 loss of appetite, upper right quadrant pain, weight loss, and night sweats which had been present for last 2&amp;nbsp;months. Computed
 tomography (CT) of the abdomen revealed a hypodense mass in the left liver lobe which was suspected as hepatocellular carcinoma.
 Histopathological examination of the CT guided biopsy specimen yielded a diagnosis of actinomycotic abscess of the liver.
 Treatment with intravenous penicillin for 6&amp;nbsp;weeks followed by a course of oral penicillin for 14&amp;nbsp;weeks resulted in complete
 cure as evidenced by clinical improvement and radiological disappearance of the lesion.
 
	Content Type Journal ArticleCategory Repo...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1062741</comments>
            <pubDate>Thu, 29 Nov 2007 16:39:31 +0100</pubDate>
            <guid isPermaLink="false">1062741</guid>        </item>
        <item>
            <title>Thy1-positive bone marrow stem cells express liver-specific genes in vitro and can mature into hepatocytes in vivo</title>
            <link>http://www.medworm.com/index.php?rid=1057243&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F254340671676675r%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The bone marrow contains stem cells that have the potential to differentiate into a variety of organ-specific mature cells,
 including the liver and the pancreas. Recently, the origin of hepatic progenitors and hepatocytes was identified to be the
 bone marrow. However, evidence that describes which cells, among all bone marrow cells, differentiate into hepatocytes, has
 not yet been presented. Based on recent reports, hematopoietic and hepatic stem cells share characteristic markers such as
 CD34, c-kit, and Thy1. In particular, both hematopoietic and hepatic stem cells express the Thy1 antigen. We investigated
 whether rat Thy1-positive bone marrow cells express liver-specific genes in&amp;nbsp;vitro, and whether transplanted Thy1 BM cells
 differentiate into mature hepat...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1057243</comments>
            <pubDate>Tue, 27 Nov 2007 15:43:19 +0100</pubDate>
            <guid isPermaLink="false">1057243</guid>        </item>
        <item>
            <title>Models for prediction of mortality from cirrhosis with special reference to artificial neural network: a critical review</title>
            <link>http://www.medworm.com/index.php?rid=1057242&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr50q00360162gt71%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Prediction of mortality of patients with cirrhosis of liver, a common and potentially fatal disease, is important for timely
 listing of patients for liver transplantation. The Child–Pugh scoring system has been widely used for predicting the outcome
 of liver cirrhosis. The Model for End-Stage Liver Disease (MELD) score has recently become popular for prediction of short-term
 mortality for organ allocation. A few studies that evaluated artificial neural network (ANN)-based model for prediction of
 outcome of cirrhosis of liver in terms of mortality have consistently shown it to be superior to Child–Pugh scoring and logistic
 regression-based models; it is worth noting that MELD score is also derived using the logistic regression model. Due to the
 inherent ability...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1057242</comments>
            <pubDate>Tue, 27 Nov 2007 15:43:19 +0100</pubDate>
            <guid isPermaLink="false">1057242</guid>        </item>
        <item>
            <title>Genome-wide transcriptome expression in the liver of a mouse model of high carbohydrate diet-induced liver steatosis and its significance for the disease</title>
            <link>http://www.medworm.com/index.php?rid=1057244&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh557k2mn981x6372%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;HCD-fed laboratory animals provide a model of early non-alcoholic fatty liver disease resembling the disease in humans. The
 genome wide gene profiling of the liver reveals the complexity of the disease, unravels novel aspects of HCD-induced hepatic
 steatosis, and helps elucidate its nature and mechanisms.
 
 
 
	Content Type Journal ArticleCategory Original ResearchDOI 10.1007/s12072-007-9025-2Authors
		Ion V. Deaciuc, University of Louisville School of Medicine Division of Gastroenterology/Hepatology, Department of Medicine 550 S. Jackson Street, ACB Bldg., Third Floor Louisville KY 40202 USAZhenyuan Song, University of Louisville School of Medicine Division of Gastroenterology/Hepatology, Department of Medicine 550 S. Jackson Street, ACB Bldg., Third Floor Louisv...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1057244</comments>
            <pubDate>Tue, 27 Nov 2007 15:43:18 +0100</pubDate>
            <guid isPermaLink="false">1057244</guid>        </item>
        <item>
            <title>Stage-specific regulation of adhesion molecule expression segregates epithelial stem/progenitor cells in fetal and adult human livers</title>
            <link>http://www.medworm.com/index.php?rid=1057245&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8vh54816297vl2t7%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Regulated expression of Ep-CAM supported proliferation in fetal hepatoblasts through weak adhesion and helped in biliary morphogenesis
 by promoting stronger adhesion in hepatoblasts during this process. Restriction of Ep-CAM expression to bile ducts in the
 adult liver presumably facilitated sequestration of stem/progenitor cells. This stage-specific and cell compartment-related
 regulation of adhesion molecules should be relevant for defining how liver stem/progenitor cells enter, exit, and remain in
 hepatic niches during both health and disease.
 
 
 
	Content Type Journal ArticleCategory Original ResearchDOI 10.1007/s12072-007-9023-4Authors
		Mari Inada, Albert Einstein College of Medicine Departments of Medicine and Pathology, Marion Bessin Liver Research Cente...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1057245</comments>
            <pubDate>Tue, 27 Nov 2007 15:38:13 +0100</pubDate>
            <guid isPermaLink="false">1057245</guid>        </item>
        <item>
            <title>Health-related quality of life and psychological correlates in patients listed for liver transplantation</title>
            <link>http://www.medworm.com/index.php?rid=1047548&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F22w2702215645931%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Patients awaiting liver transplantation are not experiencing worse physical and psychological HRQoL than other liver patients
 with cirrhosis of the liver. Therefore, there is currently no indication to increase the level of psychosocial care for liver
 transplant candidates.
 
 
 
	Content Type Journal ArticleDOI 10.1007/s12072-007-9035-0Authors
		Jolie J. Gutteling, Erasmus MC Department of Gastroenterology and Hepatology ’s Gravendijkwal 230 3015 CE Rotterdam The NetherlandsRobert A. de Man, Erasmus MC Department of Gastroenterology and Hepatology ’s Gravendijkwal 230 3015 CE Rotterdam The NetherlandsJan J. V. Busschbach, Erasmus MC Department of Medical Psychology and Psychotherapy Dr. Molewaterplein 50 3015 GE Rotterdam The NetherlandsAnne-Sophie E. Darlingt...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1047548</comments>
            <pubDate>Wed, 21 Nov 2007 16:42:01 +0100</pubDate>
            <guid isPermaLink="false">1047548</guid>        </item>
        <item>
            <title>Iodized oil accumulation in the hypovascular tumor portion of early-stage hepatocellular carcinoma after ultraselective transcatheter arterial chemoembolization</title>
            <link>http://www.medworm.com/index.php?rid=1030075&amp;cid=s_35967_20_f&amp;fid=35967&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy6u85230385482x5%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Iodized oil accumulation and retention in the hypovascular portion of early-stage HCC was frequently observed after ultraselective
 TACE, mainly in the hypovascular portion with decreased portal blood.
 
 
 
	Content Type Journal ArticleCategory Original ResearchDOI 10.1007/s12072-007-9030-5Authors
		Shiro Miyayama, Fukuiken Saiseikai Hospital Department of Diagnostic Radiology 7-1, Funabashi, Wadanaka-cho Fukui 918-8503 JapanOsamu Matsui, Kanazawa University Department of Radiology, Graduate School of Medical Science 13-1, Takara-machi Kanazawa 920-8641 JapanMasashi Yamashiro, Fukuiken Saiseikai Hospital Department of Diagnostic Radiology 7-1, Funabashi, Wadanaka-cho Fukui 918-8503 JapanYasuji Ryu, Fukuiken Saiseikai Hospital Department of Diagnostic Radiology 7-1, ...</description>
            <author>Hepatology International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1030075</comments>
            <pubDate>Wed, 14 Nov 2007 15:31:36 +0100</pubDate>
            <guid isPermaLink="false">1030075</guid>        </item>
    </channel>
</rss>
